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ABBREVIATIONS 
 
µA microampere 
µM micromolar 
1H-NMR proton nuclear magnetic resonance 
5-HT3 5-hydroxytryptamine receptor 3 family 
Å Ångström 
ACh acetylcholine 
AChBP acetylcholine-binding protein 
AChR acetylcholine receptor 
cDNA complementary deoxyribonucleic acid 
CNS central nervous system 
cRNA complementary ribonucleic acid 
Cys cysteine 
EC50 effective concentration 50 = agonist concentration 
 achieving 50% maximum response  
e.g. exempli gratia = for example 
Fig. figure 
GABA γ-aminobutyric acid 
Imax maximum current response measured at its peak in the  
 experiment  
kDa kilodalton 
LGIC ligand gated ion channel  
mM millimolar 
   
3 
nA nanoampere 
nAChR nicotinic acetylcholine receptor 
nM nanomolar 
PCR polymerase chain reaction 
pH decimal logarithm of the reciprocal of the hydrogen ion 
 activity  
rac- racemic mixture  
RACE-PCR rapid amplification of cDNA ends PCR 
RNA ribonucleic acid 
RT-PCR reverse transcription PCR 
S serine 
TM2 the second of the transmembrane regions 
Y tyrosine 
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SUMMARY 
 
Nicotinic acetylcholine receptors (nAChRs) are ligand-controlled cation channels, 
which act in fast neurotransmission at cholinergic synapses in vertebrates and 
invertebrates. They are the binding sites for nicotinoid drugs, such as nicotine and 
epibatidine. Insect nicotinic acetylcholine receptors are targets of several insecticide 
classes, such as the neonicotinoids, spinosyns and nereis toxins. This study is the 
first report about the gene identification of the α1 and α2 subunits (Lcα1 and Lcα2) 
from the sheep blowfly Lucilia cuprina as well as the full length cDNA cloning of these 
two subunits, and of the three Ctenocephalides felis (cat flea) nAChR α subunit 
genes Cfα1, Cfα2, and Cfα3 previously not available as full length versions. 
Expression of these subunits in Xenopus laevis oocytes as hybrid receptors with the 
Gallus gallus (chicken) β2 nAChR (Ggβ2) subunit resulted in functional acetylcholine-
responsive ion channels, as judged from our voltage clamp experiments. Cfα2/Ggβ2 
and Lcα2/Ggβ2 proved to be insensitive to α-bungarotoxin, while acetylcholine-
induced currents of the Cfα1/Ggβ2 and Lcα1/Ggβ2 combinations were completely 
blocked by this snake toxin. These characteristics of α-bungarotoxin sensitivity have 
been considered hallmarks of the α1 and α2 gene families and are confirmed here 
for two additional examples. The pharmacological profiles of Cfα1/Ggβ2, Cfα2/Ggβ2 
and the chicken neuronal receptor Ggα4/Ggβ2 for acetylcholine, two nicotinoids and 
6 insecticidal neonicotinoids were determined and compared on the basis of EC50, 
Hill coefficient and maximal current (relative to acetylcholine, Imax). Particularly 
remarkable was the finding that Cfα1/Ggβ2 was far more sensitive to acetylcholine, 
nicotine and neonicotinoid agonists than either Cfα2/Ggβ2 or Ggα4/Ggβ2: for the 
anti-flea neonicotinoid market compound imidacloprid the respective EC50 values 
were 0.02 µM, 1.31 µM and 13.8 µM. These results were also confirmed for two other 
insect species, Drosophila melanogaster and Lucilia cuprina, where the 
pharmacological profile of the Dmα1, Dmα2, Lcα1 and Lcα2 subunits as hybrid 
receptors with Ggβ2 in Xenopus oocyte expressions resulted in similar sensitivity 
patterns as those identified for the Ctenocephalides felis orthologs. For Cfα3/Ggβ2, 
functional expression could be achieved, but detailed analysis of acetylcholine and 
other agonists used in this study could not be performed in electrophysiological 
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experiments, due to the low signals. Collectively, the results of this study show that at 
least in a Ggβ2 hybrid receptor setting, with respect to EC50, insect α1 subunits 
confer a 9 to 65 fold higher sensitivity to neonicotinoids than seen with α2 subunits, 
which may contribute in vivo to the insect-selective action of this pesticide class. In 
an attempt to elucidate ligand structure-activity relationships, eight close derivatives 
of acetylcholine were chemically synthesized and, together with five purchased 
compounds, analysed in voltage clamp experiments for Lcα1/Ggβ2, Lcα2/Ggβ2 and 
Ggα4/Ggβ2. Comparison of the data for insect versus chicken nAChR α subunits 
allowed the definition of novel structure-activity and structure-selectivity relationships. 
In the case of N-ethyl-acetylcholine, the EC50 value of the chicken Ggα4/Ggβ2 was 
increased almost by a factor of 1000, while for both Lcα1/Ggβ2 and Lcα2/Ggβ2, 
potency remained similar to that of acetylcholine. Further derivatives with strong 
insect nAChR selectivity potential were acetyl-α-methylcholine and trimethyl-(3-
methoxy-3-oxopropyl) ammonium, followed by acetylhomocholine and trimethyl-(4-
oxopentyl) ammonium. Identification of these insect-specific structure-activity 
relationship features may provide guidance for identification or design of insect 
nAChR agonists by structure-based or in silico methods. 
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ZUSAMMENFASSUNG 
 
Nikotinische Acetylcholinrezeptoren (nAChRs) gehören zu den ligandengesteuerten 
Kationenkanälen, welche in der schnellen neuronalen Übertragung an cholinergen 
Synapsen der Vertebraten und Invertebraten mitwirken. Sie binden nikotinoide 
Wirkstoffe wie Nikotin und Epibatidin. Nikotinische Acetylcholinrezeptoren von 
Insekten sind Angriffspunkte von einigen Insektizidklassen, wie Neonikotinoide, 
Spinosyne und Nereistoxine. Diese Arbeit beschreibt zum ersten Mal die 
Genidentifizierung der α1 und α2 Untereinheiten (Lcα1 und Lcα2) der Schaf-
Schmeissfliege Lucilia cuprina und die cDNA-Klonierung dieser zwei Untereinheiten, 
wie auch der drei Ctenocephalides felis (Katzenfloh) nAChR α-Untereinheiten Cfα1, 
Cfα2 und Cfα3, deren vollständige Gensequenz bis dahin noch nicht bekannt war. 
Die Expression der Untereinheiten in Xenopus laevis Oozyten als hybride 
Rezeptoren zusammen mit der Gallus gallus (Huhn) β2 nAChR (Ggβ2) Untereinheit 
führten zur Ausbildung von Acetylcholin-gesteuerten Ionenkanälen, was durch 
Voltage-Clamp Experimente bestätigt wurde. Cfα2/Ggβ2 und Lcα2/Ggβ2 waren 
insensitiv gegenüber α-Bungarotoxin, während Acetylcholin-induzierte Ströme von 
Cfα1/Ggβ2 und Lcα1/Ggβ2 durch das Schlangengift komplett blockiert werden 
konnten. Diese Merkmale der α-Bungarotoxin-Antwort wurden als kennzeichnend für 
die α1 und α2 nAChR-Genfamilien betrachtet und in dieser Arbeit für zwei weitere 
Beispiele bestätigt. Die pharmakologischen Profile von Cfα1/Ggβ2, Cfα2/Ggβ2 und 
vom neuronalen Rezeptor des Huhns Ggα4/Ggβ2 für Acetylcholin, zwei Nikotinoide 
und 6 insektizide Neonikotinoide wurden auf der Basis vom EC50, Hill-Koeffizienten 
und maximalen Strom (relativ zu Acetylcholin, Imax) bestimmt und miteinander 
verglichen. Besonders bemerkenswert war die Erkenntnis, dass Cfα1/Ggβ2 
wesentlich sensitiver gegenüber Acetylcholin, Nikotin und Neonikotinoide war als 
Cfα2/Ggβ2 oder Ggα4/Ggβ2: für das Anti-Floh-Neonikotinoid Imidacloprid waren die 
jeweiligen EC50-Werte 0,02 µM, 1,31 µM und 13,8 µM. Diese Ergebnisse konnten 
ebenfalls für zwei weitere Insekten-Species, Drosophila melanogaster und Lucilia 
cuprina, bestätigt werden: die pharmakologischen Profile von Dmα1, Dmα2, Lcα1 
und Lcα2 Untereinheiten exprimiert als Hybridrezeptoren zusammen mit Ggβ2 in 
Xenopus-Oozyten ergaben ähnliche Sensitivitätmuster, wie die für die C. felis-
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Orthologen identifizierten. Cfα3/Ggβ2 konnte zwar funktionell exprimiert werden, 
aufgrund nur kleiner Signale war allerdings eine detaillierte elektrophysiologische 
Analyse von Acetylcholin und anderer Agonisten, die hier untersucht wurden, nicht 
möglich. Insgesamt zeigen die Ergebnisse dieser Arbeit, dass, zumindest im 
Rahmen eines Hybridrezeptors zusammen mit Ggβ2, Insekten α1 Untereinheiten 
eine 9 bis 65 fache höhere Sensitivität in Bezug auf EC50-Werte gegenüber 
Neonikotinoiden aufweisen als α2 Untereinheiten. Dies könnte die insektenselektive 
Wirkung, die bei dieser Pestizidklasse in vivo beobachtet wird, erklären. In einem 
Versuch die Liganden-Struktur-Aktivitätsbeziehungen aufzuklären, wurden 8 
Strukturanaloga von Acetylcholin chemisch synthetisiert und zusammen mit 5 
kommerziell erworbenen Verbindungen in Voltage-Clamp Experimenten mit 
Lcα1/Ggβ2, Lcα2/Ggβ2 und Ggα4/Ggβ2 analysiert. Ein Vergleich der Daten für 
Insekten versus Huhn nAChR α Untereinheiten ermöglichte es neue Struktur-
Wirkungs- und Struktur-Selektivitätsbeziehungen zu erkennen. Im Fall von N-Ethyl-
Acetylcholin erhöhte sich der EC50-Wert für Huhn Ggα4/Ggβ2 nahezu um den Faktor 
1000 relativ zu ACh, während sowohl für Lcα1/Ggβ2 als auch für Lcα2/Ggβ2 die 
Wirksamkeit bei einem ähnlichen Wert blieb wie der von Acetylcholin. Weitere 
Derivate mit deutlichem Selektivitätspotential gegenüber Insekten-nAChR waren 
Acetyl-α-Methylcholin und Trimethyl-(3-Methoxy-3-Oxopropyl) Ammonium, gefolgt 
von Acetylhomocholin und Trimethyl-(4-Oxopentyl) Ammonium. Die Identifizierung 
dieser insektenspezifischen Eigenschaften der Struktur-Aktivitätsbeziehungen könnte 
eine Orientierung zur Identifizierung oder zum Design von Agonisten der Insekten-
nAChR mithilfe strukturbasierter oder in silico Methoden liefern. 
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Voltage clamp experiments and data analysis which led to the EC50 values and Hill 
coefficients of Cfα2/Ggβ2 and Dmα2/Ggβ2 for acetylcholine, imidacloprid, 
nitenpyram, acetamiprid, dinotefuran and clothianidin, as well as identification and 
isolation of subunit genes α1, α2 and α3 from Ctenocephalides felis and Drosophila 
melanogaster, and α4 and β2 nAChR subunit genes from Gallus gallus were carried 
out by Margaret Werr*. Chemical synthesis of acetylcholine derivatives were 
performed by myself under the supervision of Dr. Michael Berger*. Trimethyl-
ethoxyethyl ammonium bromide was synthesized by Dr. Thorsten Meyer*. 1H-NMR 
quantifications were performed by Stefan Derschum* and Dr. Thorsten Meyer*.    
 
*: at MSD Animal Health Innovation GmbH in Schwabenheim an der Selz, Germany 
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INTRODUCTION 
 
Cys-loop superfamily of ligand gated ion channels 
 
Nicotinic acetylcholine receptors (nAChRs) belong to the Cys-loop (cysteine-loop) 
superfamily of the ligand gated ion channels (LGICs)1 which comprises receptors for 
acetylcholine (nAChR), GABA (GABAA and GABAC), glycine and serotonin (5-HT3). 
The LGICs act predominantly in fast neurotransmission at synaptic clefts (Han and 
Nichols 1996). Binding of neurotransmitters to the postsynaptic ion channels after 
their release from the presynaptic membrane leads to channel opening, which, in 
turn, causes depolarization and excitation, and hyperpolarization and inhibition of 
excitation of the postsynaptic membranes in the case of cation and anion channels, 
respectively (Haga 1996).  
The members of the Cys-loop superfamily all share homologous structural features 
due to their origin from a common evolutionary ancestor (Ortells and Lunt 1995, 
Tasneem et al. 2005). These receptors are pentamers of subunits, each of which has 
an N-terminal ligand-binding extracellular domain of mainly β-sheets, four 
transmembrane regions presumably in mixed α/β topology (Corringer et al. 2000), 
cytoplasmic domains containing α-helix (Unwin 2005), and a short extracellular C-
terminus. Depending on the number of different types of subunits for every receptor, 
they form homo- and heteropentamers. A highly characteristic sequence motif of all 
members of the superfamily is the 15-residue Cys-loop signature sequence formed 
by a Cys-Cys disulfide bridge, a closed loop that is located between the ligand 
binding domain and the first transmembrane helix (Ortells and Lunt 1995, Sine and 
Engel 2006).  
Functionally, inhibitory receptor ion channels selective for anions (receptors for 
GABA and glycine) and excitatory receptor ion channels selective for cations 
(nAChRs and serotonin receptors) can be distinguished within the Cys-loop 
superfamily. Their anion/cation selectivity appears to be determined by the amino 
                                                          
1 database: http://www.ebi.ac.uk/compneur-srv/LGICdb/LGICdb.php 
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acids lining the selectivity filter of the ion channel (Keramidas et al. 2004), which is 
mostly formed by the second transmembrane regions (TM2) of the five subunits. This 
organization of the selectivity filter is confirmed by mutational studies within or nearby 
the TM2 helices, which, depending on the exchanges, could cause the switch of ion 
selectivity from cations to anions (Galzi et al. 1992, Gunthorpe and Lummis 2001), 
and vice versa (Connolly and Wafford 2004, Keramidas et al. 2000). Due to the 
common evolutionary ancestor of the cation- and anion-conducting LGICs, there are 
several amino acids conserved, in some cases even across all members of the Cys-
loop superfamily, in others within certain subtypes of the receptors. Most of these 
conserved amino acids contribute to ligand binding or ion gating (Le Novere and 
Changeux 2001, Sine and Engel 2006).  
Although the narrowest point of the membrane pore, formed by amino acids near the 
intracellular end of TM2, determines ion flow through the receptor channel, the entire 
inner surface of the central vestibule (Fig. 1A) is a part of the selectivity filter. In the 
case of nAChR, the negatively charged groups lining their surface have the capacity 
to interact with cations and thereby may act stabilizing to their presence, which would 
increase the concentration of cation in the vestibule (Gunthorpe and Lummis 2001, 
Jensen et al. 2002, Keramidas et al. 2000, Unwin 2005, Wilson and Karlin 2001). The 
binding of the neurotransmitter leads to a conformation change in the ligand binding 
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domain which causes a reorientation of the TM2 helices resulting in their rotation and 
thus opening of the receptor channel (Miyazawa et al. 2003). In the case of the 
Torpedo electroplaque acetylcholine receptor, the narrowest point of the resting gate 
has a diameter of about 3Å, while through helix motion upon ACh binding the gate 
size increases to about 8Å (Unwin 1995).   
 
Nicotinic Acetylcholine Receptor 
 
There are two groups of acetylcholine receptors (AChRs) differing in eponymous 
selective alkaloid agonists from natural sources: nicotinic AChR was named after 
nicotine from the tobacco plant (Nicotiana tabacum) whereas muscarinic AChR has 
its name from muscarine, a cholinergic drug first isolated from the mushroom fly 
agaric (Amanita muscaria) (Daly 2005). While nAChRs are ligand gated cation 
channels, muscarinic AChRs belong to the G-protein-coupled receptors. 
The paradigmal nAChR from Torpedo is a glycoprotein of 290 kDa (Unwin 2005) 
consisting of five subunits, and it is thought that all nAChRs share this general 
structural setup. The quaternary structure of the pentamer is barrel-like and about 
160 Å long (Arias 2000, Unwin 2005). The individual receptor subunits are of similar 
size (about 30 Å × 40 Å × 160 Å) and three-dimensional fold. In the nomenclature of 
the nAChR subunits, a distinction is drawn between α and non-α (β, γ, δ, ε) subunits: 
two adjacent cysteine residues, thought to be important for ACh binding, define 
nAChR α subunit, while non-α subunits lack this motif (Connolly and Wafford 2004, 
Le Novere and Changeux 1995, Le Novere et al. 2002, Ortells and Lunt 1995). To 
date, there is a large number of different subunits (10-30) identified in all vertebrate 
and invertebrate species. So potentially, many different subunit combinations are 
possible to form a heteropentameric receptor. However, not all subunits 
arrangements appear to be able to form functional ion channels and the number of 
proven pentamers is much lower than the theoretical number of potential 
combinations (Millar 2003). Nevertheless, the still considerable functional diversity of 
nAChRs is based on diversity of subunits (Le Novere et al. 2002, Millar 2003, Millar 
and Denholm 2007). 
Introduction 
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The nAChR is the best-investigated member of the Cys-loop superfamily and 
deemed to be its prototype. The state of knowledge of AChR has progressed in the 
last 40 years due to the availability of a source of abundant and highly enriched 
receptors: the electric organ of the electric ray, Torpedo. This specialized muscle-
derived organ offers a high concentration of nAChRs which can be solubilized by 
detergents from the membrane with retained activity in vitro (Dolly and Barnard 1984, 
Grutter and Changeux 2001). An α-toxin from the venom of the snake Bungarus, α-
bungarotoxin, proves to be highly selective for nAChRs and is shown to bind 
irreversibly to the Torpedo nAChR (Lee 1972, Lee and Chang 1966). This enables 
isolation and purification of nAChR from Torpedo by snake toxin affinity 
chromatography (Changeux et al. 1970, Corringer et al. 2000). Further, in the snail 
Lymnaea stagnalis a soluble ACh-binding protein (AChBP) was discovered (Smit et 
al. 2001) that is related to the N-terminal domain of the α-subunits of the nAChRs. 
Thus, the crystal structure of AChBP at 2.7Å resolution does predict structural 
properties of the nAChR ligand-binding domain, since almost all conserved nAChR 
residues are also present in this snail protein (Brejc et al. 2001). Recent electron 
microscopic experiments on tubular crystals from Torpedo postsynaptic membranes 
at 4 Å resolution (Unwin 2005), X-ray structures of extracellular domain of the mouse 
nAChR α1 subunit bound to α-bungarotoxin at 1.94 Å (Dellisanti et al. 2007), and of 
prokaryotic LGICs from the gram negative bacterium Erwinia chrysanthemi (Hilf and 
Dutzler 2008) and from the cyanobacterium Gloebacter violaceus (Bocquet et al. 
2009, Hilf and Dutzler 2009) at 3.3 Å and 3.1 Å resolution, respectively, provide an 
insight into the architecture of nAChR and LGICs in general. At a functional level, the 
possibility of expressing correctly folded ion channels in Xenopus laevis oocytes 
permits structural ligand binding, electrophysiology and receptor regulation studies 
on nAChRs (Dascal 1987, Snutch 1988).   
 
Vertebrate nAChRs 
To date, seventeen different nAChR subunits have been identified in vertebrates (α1-
α10, β1-β4, γ, δ, ε). Most nAChRs coassemble into heteropentameric receptors 
containing at least one type of α subunit and one type of non-α subunit, but some 
receptors are homopentamers formed by a single α subunit type (e.g. α7) (Millar and 
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Gotti 2009). The pentamers of vertebrate muscle-type nAChRs have a fixed 
stoichiometry of four differend subunits ((α1)2β1δε/γ, Fig. 2) and are present 
postsynaptically at the neuromuscular junction. Neuronal nAChRs are located at 
presynaptic and postsynaptic membranes in the autonomic ganglia and the central 
nervous system (Jensen et al. 2005, Wonnacott 1997). The subunit stoichiometries 
of the neuronal representatives of nAChR subtypes are less clearly defined. In 
general, the most heteromeric neuronal nAChRs seem to be coassemblies of two α 
subunits (one or two types) and three β subunits (one or two types) (Millar 2003, 
Millar and Gotti 2009). Neuronal nAChR expression is tissue-specific and the 
predominant subunits in the central nervous system have been identified as α7, α4 
and β2. By contrast, in the autonomic ganglia, abundant expression of α3 and β4 is 
noted (Jensen et al. 2005, Paterson and Nordberg 2000). The difficulty of 
investigating subunit combinations arises also out of discrepancies in results 
obtained from recombinant versus native nAChR (Millar and Gotti 2009). 
The diversity of nAChR subunit compositions gives rise to different physiological and 
pharmacological receptor properties. In humans, nAChRs represent drug targets in 
the pathology of several neurological and neuromuscular disorders. These include 
neuropathic pain, Alzheimer’s and Parkinson’s diseases, myasthenia gravis, 
congenital myasthenic syndromes, schizophrenia, depression, attention deficit 
disorders, tobacco addiction, epilepsy and Tourette’s syndrome (D'hoedt and 
Bertrand 2009, Jensen et al. 2005, Lindstrom 2000, 2003, Livett et al. 2006, Paterson 
and Nordberg 2000, Steinlein 2007, Taly et al. 2009, Weiland et al. 2000). 
Interestingly, some partial agonists and antagonists addressing specific nAChR 
subtypes as well as cholinesterase inhibitors show efficacy in the treatment of alcohol 
Figure 2: Various heteropentameric and homopentameric human nAChR subtypes (modified from Jensen et al. 
2005). Red ovals: ACh binding sites. 
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abuse and dependence (Rahman and Prendergast 2012). There is evidence of 
deleterious, but also beneficial connections between nicotine exposure and several 
diseases. Smokers have a lower prevalence of Alzheimer’s and Parkinson’s diseases 
(Brenner et al. 1993, Quik et al. 2009), whereas depression, attention deficit 
disorders and schizophrenia are over-represented among smokers. Thereby it is 
assumed that smoking may occasionally serve as a kind of self-medication 
(Glassman et al. 1990, Lohr and Flynn 1992, Mineur and Picciotto 2010, Pomerleau 
et al. 1995). In fact, there is evidence that nicotine consumption has antidepressant 
property (Salin-Pascual et al. 1995), can improve attention and memory, and 
significantly decreases attention deficit disorder symptoms (Levin and Simon 1998).                   
In addition to the nervous system, many components of the cholinergic system are 
found also in non-neuronal cells (Sharma and Vijayaraghavan 2002, Wessler and 
Kirkpatrick 2008). There is evidence of nAChRs being involved in regulation of cell 
proliferation, in apoptosis, migration, invasion, angiogenesis and in secretion 
(Egleton et al. 2008). Nicotine is found to upregulate the nAChRs during continuing 
exposition (Vallejo et al. 2005), and to stimulate tumor growth and survival of non-
neuronal cells (Egleton et al. 2008). Further, nAChRs expressed in lymphocytes are 
thought to be involved in inflammation regulation (Borovikova et al. 2000, Wessler 
and Kirkpatrick 2008) and modulation of immune system function (Fujii et al. 2012, 
Kawashima and Fujii 2000) like T-cell activation (Egleton et al. 2009) or regulation of 
antibody production (Kawashima et al. 2007).  
  
Insect nAChRs  
In contrast to their vertebrate counterparts, insect nAChRs are less well explored. To 
date, they are the smallest nAChRs gene families known (Jones et al. 2007) with e.g. 
10 genes in Drosophila (D.) melanogaster (Dmα1-Dmα7, Dmβ1-Dmβ3, (Littleton and 
Ganetzky 2000, Sattelle et al. 2005)) and Anopheles gambiae (Agα1-Agα9, Agβ1, 
(Jones et al. 2005a)), 11 genes in Apis mellifera (Amα1-Amα9, Amβ1-Amβ2, (Jones 
et al. 2006)), and 12 genes in Bombyx mori (Bmα1-Bmα9, Bmβ1-Bmβ3, (Shao et al. 
2007)). Other insect nAChR subunit genes have been cloned from e.g. planthopper 
Nilaparvata lugens (Liu et al. 2006), green peach aphid Myzus persicae (Huang et al. 
1999), asiatic honey bee Apis cerana cerana (Yu et al. 2011), desert locust 
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Schistocerca gregaria (Jones et al. 2005b, Marshall et al. 1990),  and nicotine-
insensitive tobacco hornworm Manduca sexta (Eastham et al. 1998).  
Based on sequence homology analysis, the nAChR gene families of D. 
melanogaster, Anopheles gambiae and Apis mellifera possess groups of subunits 
that are highly conserved between these species (with >60% sequence identity). 
However, each insect gene family also have at least one divergent subunit with low 
sequence homology (with <20% sequence homology), which could stand for species-
specific receptor subtypes (Jones et al. 2007). Furthermore, some insect nAChR 
subunits are known to undergo alternative splicing and RNA editing (Jones et al. 
2005a, 2006, Lansdell and Millar 2000a, Sattelle et al. 2005), what also could 
generate species-specific receptor subtypes. But presently, knowledge about insect 
nAChR subtype diversity in the nervous system is still fragmentary (Tomizawa and 
Casida 2001).   
In vertebrates, the neuromuscular transmission is cholinergic and the vast majority of 
excitatory neurotransmission in the brain are mediated by glutamate (Dingledine et 
al. 1999). This is fundamentally different in insects, where the main excitatory 
neurotransmitter in the brain is acetylcholine, while the synaptic transmission at the 
neuromuscular junction is glutamatergic (Millar and Denholm 2007, Sattelle 1980). 
Due to the fact that the insect nervous system is one of the richest sources of 
nAChRs (Breer and Sattelle 1987, Dudai 1978), it provides the opportunity to exploit 
these receptor ion channels as selective targets for nerve poisoning insecticides 
(Jeschke 2007, Matsuda et al. 2001). Recent surveys report that by market share, 
about 90% of synthetic insecticides are neurotoxins acting on only four targets: 
acetylcholinesterases, the voltage-dependent sodium channels, the GABA-gated 
chloride channels, and nAChRs (Tomizawa and Casida 2003). Insecticides binding to 
nAChRs have a market share in agriculture of ~24% (Jeschke et al. 2011), and the 
by far largest and commercially most important insecticide class addressing these 
receptors are the neonicotinoids with the forerunner imidacloprid, which is marketed 
since 1991 (Jeschke and Nauen 2008, Millar and Denholm 2007). To date, 
imidacloprid is the major selling insecticide in the world and holds over 40% of the 
whole neonicotinoid market (Jeschke et al. 2011).  
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Figure 3: Structures of imidacloprid and thiacloprid, their desnitro/descyano-counterparts, mesomeric structure 
of imidacloprid, and nicotine in ionized and nonionized form.  
Nicotine is a naturally occurring insecticide (Soloway 1976), but its commercial use is 
limited due to its high toxicity to vertebrates, which is higher than its insecticidal 
potency (Millar and Denholm 2007). In contrast, neonicotinoids, with their structural 
similarity to nicotine and a common mode of action (Tomizawa and Casida 2003) are 
more than 100-fold selective for insect over vertebrate nAChRs. Yamamoto et al. 
(1998) points out the significance of compound hydrophobicity in selective action of 
insecticides. The amino group nitrogen atom of nicotinoids is ionized under 
physiological conditions. This ionisation is essential for interaction with vertebrate 
nAChRs but results in poor penetration of the ion-impermeable barrier of insect CNS 
(Tomizawa and Casida 2003, Yamamoto et al. 1998). In contrast, neonicotinoids are 
not protonated at physiological pH (Fig. 3), which allows for more efficient penetration 
into the insect CNS, while the formation of zwitterionic mesomeric structures ensure 
potency on insect nAChRs as well as selectivity over vertebrate receptors (Tomizawa 
and Casida 2003, Tomizawa et al. 2000). Remarkably, desnitro-imidacloprid and 
descyano-thiacloprid are considerably more potent on vertebrate than on insect 
nAChRs (Matsuda et al. 2001, Tomizawa and Casida 2003, Tomizawa et al. 2000), 
indicating the nitro or cyano substituents enabling the mesomeric structures are 
crucial for insect versus vertebrate nAChRs selectivity (so-called “magic” nitro and 
“magic” cyano groups) (Tomizawa and Casida 2003). This could be explained by 
assumption of the architecture differences in insect versus vertebrate nAChR ligand 
binding sites: the negatively charged nitro/cyano groups interact with cationic amino 
acid residue(s) in insect receptors, while in the case of the positively charged 
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moieties in desnitro/descyano compounds, interaction with insect nAChRs is weak, 
but strong with anionic subside mammalian nAChRs (Tomizawa and Casida 2005, 
Tomizawa and Casida 2011, Tomizawa et al. 2000). 
The molecular definition of the insecticide target site in insect nAChRs is still 
incomplete due to the difficulties in the expression of recombinant receptor channels 
in heterologous expression systems (Millar 1999, Millar and Lansdell 2010). Except 
for the homomeric Schistocerca nAChR α1 expressed in Xenopus oocytes (Amar et 
al. 1995, Marshall et al. 1990), functional expression of other insect nAChRs in 
Xenopus oocytes is limited to trans-species hybrid receptor formation of insect α 
subunits with chicken or rat β2 subunits (Bertrand et al. 1994, Millar 1999, 2009, 
Millar and Lansdell 2010, Tomizawa et al. 2005). Similarly, expression of insect 
nAChRs in cultured mammalian as well as insect cell lines is also only possible by 
coexpression with vertebrate β2 subunits (Huang et al. 1999, Lansdell and Millar 
2000b, Lansdell et al. 1997, Millar 2009). Thus, exploring pharmacological profiles of 
insect nAChRs in the currently avaliable recombinant settings clearly does not reflect 
the in vivo situation and requires stringent controls and cautious interpretation.      
 
Architecture of the ACh binding site 
One way to obtain molecular insights in the nAChR binding site is the analysis of 
crystal structures. While the generation of X-ray structures of the entire nAChR 
channel has so far not been successful, crystallization of mollusk AChBPs has been 
achieved. Although lacking the ion channel domain, based on homology 
considerations, AChBP is thought to be equivalent to the nAChR binding domain and 
contains many of the residues thought to be crucial for tertiary structure and ligand 
binding (Brejc et al. 2001). In concordance with this view, AChBP binds known 
nAChR agonists and competitive antagonists (Brejc et al. 2001, Smit et al. 2001). 
Crystal structures of Lymnaea stagnalis (Ls) AChBP in complex with imidacloprid and 
clothianidin (Ihara et al. 2008), and with nicotine and carbamylcholine (Celie et al. 
2004), respectively, and of Aplysia californica (Ac) AChBP in complex with thiacloprid 
and imidacloprid (Talley et al. 2008) allow first conclusions about the interactions of 
agonists with amino acid residues of the binding pocket. Further X-ray studies with 
neonicotinoids and nicotinoids interacting with these two AChBPs show that Ac-
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AChBP exhibits high affinity for neonicotinoids, while Ls-AChBP has low 
neonicotinoid and high nicotinoid binding affinity. Thus, it is proposed that Ac-AChBP 
could serve as a surrogate for insect nAChRs and Ls-AChBP for vertebrate nAChRs 
(Tomizawa and Casida 2009, Tomizawa and Casida 2011). 
The ACh binding site is located at the interface between two subunits and consists of 
two components: the so-called “principal” and “complementary” sides (Corringer et al. 
1995). The principal component is on the α subunit and built up of the three loops A-
C. The three further peptide loops D-F are part of the complementary side located on 
the non-α subunit in heteropentamers, and on the neighbouring α subunit in 
homopentamers like α7, respectively (Corringer et al. 2000, Karlin 2002). Thus, 
heteromeric and homopentameric nAChRs have typically two and five ACh binding 
sites, respectively (Fig. 2).   
Some functionally significant amino acids of the six loops involved in ACh binding are 
conserved across the nAChRs (Brejc et al. 2001, Corringer et al. 2000, Jensen et al. 
2005, Sine and Engel 2006). Thus, the variable amino acids are likely to contribute to 
the subunit and species selectivity, as well as to the distinct pharmacological profiles 
of different nAChRs (Corringer et al. 1998, Grutter and Changeux 2001, Tomizawa 
and Casida 2009, Tomizawa and Casida 2011). Among the conserved amino acids, 
there are two adjacent cysteine residues located at the turn of β hairpin folded loop C 
(Brejc et al. 2001) and enclosed by two tyrosines (Abramson et al. 1989, Dennis et 
al. 1988). These two aromatic residues build together with tyrosine from loop A (Galzi 
et al. 1990) and two tryptophans from loops B (Dennis et al. 1988) and D (Chiara and 
Cohen 1997) the so-called “aromatic box” (Fig. 4), which forms the binding site for 
the positively charged quaternary ammonium group of ACh (Jensen et al. 2005), 
probably via forming cation-π interaction with a tryptophan of loop B (Dougherty and 
Stauffer 1990, Jensen et al. 2005, Zhong et al. 1998). Zhong et al. (1998) found that 
a decrease in cation-π binding ability for various tryptophan derivatives at this 
defined position in loop B increases the EC50 (effective agonist concentration for 50% 
maximum response) values for ACh. In the ligand-free form of the receptor, loop C 
projects away from the body of the α subunit, whereas in ligand-bound conformation 
loop C is closer to loops A and B surrounding the ligand, burying them and tightly 
capping the binding pocket (Tomizawa and Casida 2009, Unwin 2005). Furthermore, 
the ligand seems to form contacts more with the principal side of the binding pocket 
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Figure 4: Ligand binding site of the nAChRs (modified from Matsuda et al. 2005) 
rather than with the complementary side, an arrangement known for nicotine and 
carbamylcholine bound to AChBP (Celie et al. 2004). Shimomura et al. (2004) found 
that the single amino acid between the tyrosine and the two adjacent cysteins in loop 
C as well as the loop B-C interval length differ considerably between insect and 
vertebrate α subunits, and these differences have an influence on neonicotinoid 
sensitivity (Matsuda et al. 2005). Loop D includes basic residues, which can 
contribute to the binding stability of neonicotinoids in insect nAChRs (Matsuda et al. 
2009). In agreement with these findings, mutations in loop D of chicken α7 and α4/β2 
receptors to corresponding basic residues result in significant enhancement of 
neonicotinoid sensitivity (Shimomura et al. 2002, 2006, Toshima et al. 2009). Further 
mutation studies highlighted the possible role of loop E as a contributor to 
neonicotinoid binding efficiency (Amiri et al. 2008).   
Pharmacological profiles of native nAChRs show that - similar to the findings with 
mammalian nAChRs - α-bungarotoxin-sensitive and -insensitive nAChR forms exist 
in insects (Thany et al. 2007). Based upon studies with D. melanogaster hybrid 
receptors, Dmα1- and Dmα3-containing nAChRs are sensitive to α-bungarotoxin, 
while Dmα2- and Dmα4-containing hybrid receptors are insensitive (Bertrand et al. 
1994, Lansdell et al. 2000a,b, Schulz et al. 1998, Tomizawa et al. 2005). Some other 
naturally occurring toxins bind to different regions of the binding pocket, as is shown 
for the cone snail peptide α-conotoxin ImI, the plant alkaloid methyllycaconitine and 
the tree frog alkaloid epibatidine (Taylor et al. 2007). Since nitenpyram resistant 
mutants of D. melanogaster are also cross-resistant to imidacloprid and 
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thiamethoxam (Perry et al. 2008), neonicotinoids appear to bind to an equivalent 
region. But the neonicotinoid binding site seems to overlap only partially with that of 
α-bungarotoxin (Nishiwaki et al. 2003, Tomizawa et al. 2005) or epibatidine 
(Tomizawa et al. 2005).  
An additional way of studing features of the binding site in nAChRs is structure-
activity data analysis. Schmitt (2000) classified in his review an impressive data set 
over non-peptidic ligand structure-affinity relationships on CNS nAChRs α4/β2 and 
α7. The compounds were grouped into five classes based on structures of their 
cationic centers and hydrogen bond acceptor/π moieties – the two crucial features for 
activity on nAChRs (Schmitt 2000). For insect nAChRs ligands, similar studies have 
not yet been reported.    
While particularly the last decade has seen a tremendous increase in nAChR 
structural knowledge, there are many details that are still not known definitely about 
interaction between ligand and binding site of nAChRs. So until the in vivo subunit 
compositions, as well as the full crystal structure of defined nAChRs are established, 
structure-activity data interpretation will remain limited.       
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AIM OF THE STUDY 
 
Part I: Pharmacological characterisation of nAChR α subunits of the cat flea 
Ctenocephalides felis  
By market share, nAChR is one of the four insecticidal targets of capital importance 
(Tomizawa and Casida 2003). However, nAChR gene sequences are only known for 
a limited number of pest insects. Prevention and treatment of ectoparasite infestation 
of companion animals, such as cats and dogs, is a major market in animal health. 
The International Federation for Animal Health estimated the count of the world cat 
population to be about 220 million (in 2010, IFAH 2012). Of the many parasites of 
cats, the cat flea Ctenocephalides (C.) felis is a major source of discomfort and a 
transmitter of diseases (Rust 2005). Some of established cat flea insecticides are 
neonicotinoids such as imidacloprid, nitenpyram and dinotefuran (Rust 2005), which 
act on nAChRs. 
At the beginning of this study, only a single report on nAChRs of C. felis had been 
published, reporting the partial gene cloning of eight nAChR subunits Cfα1 – Cfα4, 
Cfα7, Cfα8 and Cfβ1, and providing limited functional studies by radioligand binding 
experiments (Bass et al. 2006). The initial task of the first part was to identify and 
clone the full length cDNA sequences of the Cfα1, Cfα2 and Cfα3 genes based on 
our own degenerate primer RT-PCR data (not shown) and on the published partial 
cDNA sequences DQ237865, DQ237866 and DQ237867 (Bass et al. 2006). The 
second task was the functional expression of the new subunits in Xenopus oocytes 
as trans-species heteromers with chicken β2 (Ggβ2) subunit. Furthermore, these 
three hybrid receptors (Cfα1/Ggβ2, Cfα2/Ggβ2 and Cfα3/Ggβ2) were 
pharmacologically characterized in two electrode voltage clamp experiments with the 
natural ligand ACh, the standard agonists nicotine and epibatidine, and the 
paradigmatic inhibitor α-bungarotoxin. In the fourth task, the pharmacology of the 
neonicotinoid market products imidacloprid, nitenpyram, acetamiprid, thiacloprid, 
dinotefuran and clothianidin (Fig. 5) was determined for the C. felis subunits Cfα1 
and Cfα2, and compared with those of the chicken α4 subunit, in their respective 
chicken β2 subunit heteromer context (Cfα1/Ggβ2, Cfα2/Ggβ2, Ggα4/Ggβ2). 
Aim of the study 
  
25 
 
Figure 5: Chemical structures of nicotinoids and neonicotinoids applied in this study. From Dederer et al. 2011.   
Additionally, in the fifth task, the pharmacology of these C. felis subunits was 
compared with the respective subunits of the insect model organism D. 
melanogaster.       
 
 
 
Part II: Molecular cloning and functional expression of Lucilia cuprina α subunits – 
pharmacology and study of structure-activity relationships using chemically 
synthesized acetylcholine derivatives 
The sheep blowfly Lucilia (L.) cuprina is the causative agent of major animal distress 
and economic losses in sheep husbandry in subtropical areas. Spinosad is an 
established blowfly insecticide (Levot et al. 2002), known to act on receptors 
containing nAChR subunit α6 (Baxter et al. 2010, Perry et al. 2007). So far, no 
compound of the neonicotinoid class has been registered as a market product 
against L. cuprina. In bioscreen experiments in MSD Animal Health Innovation 
GmbH, imidacloprid and nitenpyram showed some killing efficacy on L. cuprina 
larvae (Dr. H. Williams, unpublished observations). This prompted our interest to 
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investigate the nAChR subunits of this important insect parasite as potential pesticide 
targets.  
In part II of this study the following subprojects were pursued: first, the genes of two 
L. cuprina nAChR subunits Lcα1 and Lcα2 were identified and their full length cDNAs 
cloned. In the second task, these two new subunits were functionally expressed in 
Xenopus laevis oocytes as trans-species heteromers with the chicken nAChR β2 
subunit. The third task was – analogous to part I – the pharmacological 
characterisation of the two L. cuprina heterologous nAChRs with ACh, the nicotinoids 
nicotine and epibatidine, the antagonist α-bungarotoxin, and, for comparison, with the 
neonicotinoid imidacloprid. The fourth task comprised the chemical synthesis of eight 
close ACh derivatives and their characterisation together with an additional five 
purchased ACh analoga (for structures see Figure 6, p. 32). In the last task, 
structure-activity relationships for agonist action of these compounds were 
established and compared for Lcα1/Ggβ2, Lcα2/Ggβ2 and Ggα4/Ggβ2 receptors. 
The results were expected to give guidance in the identification of fly-specific 
compounds. 
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RESULTS AND DISCUSSION 
 
This study is the first report about de novo full length identification and cloning of 
three C. felis nicotinic acetylcholine receptor genes α1, α2 and α3 (cfα1, cfα2, cfα3), 
as well as two L. cuprina genes α1 and α2 (lcα1 and lcα2). The deduced 
polypeptides from these sequences contain motifs typical for nicotinic receptor α 
subunit ligand binding sites within the putative extracellular domains (Albuquerque et 
al. 2009, Arias 1997, Corringer et al. 2000): the cysteine loop and the loops A-C with 
a number of highly conserved amino acid residues. Furthermore, four 
transmembrane helices typical for nAChR subunits and LGICs in general 
(Albuquerque et al. 2009, Arias 1997, Corringer et al. 2000) are predicted in the 
polypeptide sequence analysis of all five subunits. Finally, every subunit contains the 
highly conserved amino acid residues of the nAChR ion channel ‘rings’ within and 
neighbouring to the second transmembrane helix TM2.  
To examine functionality and properties of the full length nAChR cDNAs identified in 
this study, they were coexpressed in Xenopus laevis oocytes with the chicken β2 
(Ggβ2) subunit (Bertrand et al. 1994) and studied by two-electrode voltage clamp 
assays. In all cases, the electrophysiological functionality of the α subunits was 
shown by application of ACh, which led to dose-dependent currents. These currents 
were rather weak in the case of Cfα3/Ggβ2 and Lcα1/Ggβ2 (largely nA range), but 
strong in the case of Cfα1/Ggβ2, Cfα2/Ggβ2 and Lcα2/Ggβ2 (up to 30µA). In the 
case of Cfα2/Ggβ2 and Lcα2/Ggβ2, the EC50 values for ACh were 9.0 µM and 5.37 
µM, respectively. In contrast, Cfα1/Ggβ2 and Lcα1/Ggβ2 were much more sensitive 
to ACh activation with EC50 values of 50 nM and 80 nM, respectively. For Cfα3/Ggβ2, 
an EC50 for ACh could not be determined in Xenopus two electrode voltage clamp 
experiments, due to the low signals, which also precluded detailed analysis of other 
agonists used in this study. A similar picture was seen for the corresponding D. 
melanogaster orthologs: for Dmα2/Ggβ2, strong ACh-elicited currents and an EC50 of 
6.6 µM were detected, while the combination Dmα1/Ggβ2 proved to be much more 
sensitive than the Dmα2 combination, with an EC50 of 70 nM. Like Cfα3/Ggβ2, 
Dmα3/Ggβ2 also gave only small ACh-dependent currents, precluding EC50 
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determination for this ligand and other agonists used in this study. Cfα2/Ggβ2 and 
Lcα2/Ggβ2 were insensitive to α-bungarotoxin at 2 µM, while ACh-induced currents 
of the Cfα1/Ggβ2 and Lcα1/Ggβ2 combinations were completely blocked by this 
concentration of snake toxin. These characteristics of α-bungarotoxin response have 
been postulated as hallmarks of insect α1 and α2 subunits (Bertrand et al. 1994, 
Lansdell and Millar 2000b), a conclusion confirmed in this study. 
Further, the four newly identified α1 and α2 subunits were tested upon their nicotine, 
epibatidine and imidacloprid sensitivity. In the case of both α1 hybrid subunit 
combinations, as well as the comparative Dmα1/Ggβ2, even low epibatidine 
concentrations led to a persistent activation of the receptors, which precluded the 
determination of proper dose response curves. Repeated epibatidine application 
resulted in pronounced desensitization of Lcα2/Ggβ2, while nicotine desensitized 
both Lcα1/Ggβ2 and Lcα2/Ggβ2. As these effects could not be reversed by washing, 
the calculated EC50 and Imax values have to remain tentative, and Hill coefficients 
were not determined. The neonicotinoid imidacloprid gave rise to only small currents 
on Lcα1/Ggβ2 that made dose-response considerations difficult and led only to 
tentative EC50 values. The sensitivity of Cfα1/Ggβ2 and Lcα1/Ggβ2 combinations to 
agonists in general was one or two orders of magnitude higher compared to 
Cfα2/Ggβ2 and Lcα2/Ggβ2. The (neo)nicotinoid agonist potencies for both α2 hybrid 
subunit combinations Cfα2/Ggβ2 and Lcα2/Ggβ2 decreased in the following order: 
epibatidine > imidacloprid > nicotine. The EC50 values for imidacloprid and nicotine 
on the both α1 hybrid subunit combinations were all approximately 20 nM. The D. 
melanogaster orthologs Dmα1 and Dmα2 in combinations with Ggβ2 showed a 
similar picture concerning EC50 values and orders of potency as the four new α 
subunits – a finding different from earlier reports (Ihara et al. 2003). The nicotinoid 
and neonicotinoid activity data obtained from the three insect receptor subunit 
studies were compared with those from the chicken neuronal receptor Ggα4/Ggβ2 
also expressed in Xenopus oocytes. Epibatidine treatment led to persistent activation 
of Ggα4/Ggβ2 that could only insufficiently be washed off, which precluded EC50 
determinations. Imidacloprid showed lower potency on Ggα4/Ggβ2 than nicotine, 
with EC50 values of 13.8 µM and 760 nM, respectively. Thus, imidacloprid was 690-
fold less potent on the chicken receptor Ggα4/Ggβ2 than on Cfα1/Ggβ2 and 
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Lcα1/Ggβ2, and 11-fold and 22-fold less potent than on Cfα2/Ggβ2 and Lcα2/Ggβ2, 
respectively. 
In addition, both cat flea nAChR α1 and α2 subunits, as well as, for comparison, 
Dmα1/Ggβ2, Dmα2/Ggβ2 and Ggα4/Ggβ2, were tested for their sensitivity to further 
neonicotinoids derivatives. The agonist potencies of all nicotinoids and 
neonicotinoids tested on Cfα2/Ggβ2 increased in the following order: dinotefuran < 
nitenpyram < nicotine ~ acetamiprid < clothianidin < imidacloprid < epibatidine, while 
on Cfα1/Ggβ2 the order was dinotefuran < nitenpyram < clothianidin < acetamiprid < 
nicotine < imidacloprid. While the EC50 of imidacloprid (1.31 µM) on the potential 
neonicotinoid target Cfα2/Ggβ2 was in an activity range that could perhaps be in 
agreement with its potent anti-flea activity, the potency of the other flea control 
market products nitenpyram (EC50 = 24.4 µM) or dinotefuran (EC50 = 124.8 µM) 
appeared too low to explain their in vivo activity based on interaction with this insect 
receptor subunit. The sensitivity of the Cfα1/Ggβ2 hybrid subunit combination to 
neonicotinoid ligands was about 10-100 times higher compared to Cfα2/Ggβ2 with 
EC50 values mostly in the nanomolar range, except for dinotefuran (EC50 = 4.19 µM). 
Further, Imax determinations with ACh as standard showed that all nicotinoid and 
neonicotinoid ligands investigated here were partial agonists on Cfα1/Ggβ2. On 
Cfα2/Ggβ2, clothianidin behaved as a superagonist, dinotefuran and epibatidine as 
full agonists, while all the other ligands were partial agonists. Thiacloprid was also an 
agonist of Cfα2/Ggβ2 and Cfα1/Ggβ2, but EC50 or Imax values could not be 
determined, because in contrast to other neonicotinoids, repeated application of this 
derivative led to a gradual loss of signal, even at low concentrations. Replacement of 
Cfα1 and Cfα2 by their D. melanogaster orthologs Dmα1 and Dmα2 in Xenopus 
expression and electrophysiology experiments with the neonicotinoid agonists 
nitenpyram, acetamiprid, clothianidin and dinotefuran revealed similar EC50 values 
and orders of potency as for their C. felis counterparts. Dose-response investigations 
of neonicotinoids on Ggα4/Ggβ2 in Xenopus oocytes showed that all 5 neonicotinoid 
compounds investigated were partial agonists in the µM to mM range. EC50 
determinations showed that nitenpyram was 73-fold, acetamiprid 85-fold, dinotefuran 
244-fold and clothianidin 142-fold less potent on the chicken receptor Ggα4/Ggβ2 
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than on Cfα1/Ggβ2. These selectivities may provide a potential rational definition of 
structure-activity and structure-selectivity relationships for insecticide design. 
The electrophysiology comparisons of the C. felis, L. cuprina and D. melanogaster α 
subunits in this study suggest that the insect α1 subunit may be a better candidate 
for being a crucial part of the in vivo neonicotinoid target than insect α2, which has 
been in the center of many previous investigations. This notion is supported by a 
number of earlier studies. Liu et al. (2009) showed differences in EC50 values for ACh 
and imidacloprid on Nilaparvata (N.) lugens nAChR subunits Nlα2 or Nlα1 
coexpressed with the rat β2 subunit in Xenopus oocytes. Whereas ACh was twofold 
more potent on Nlα1/Rnβ2 than on Nlα2/Rnβ2, imidacloprid shows 15-fold more 
potency (Liu et al. 2009). Further, in N. lugens as well as in D. melanogaster, target 
site-based neonicotinoid resistance has been reported. In N. lugens, Y151S mutations 
have been identified in the nAChR subunits α1 and α3 that have been implicated in 
neonicotinoid resistance (Li et al. 2010, Liu et al. 2005, 2006, 2009, Yixi et al. 2009). 
Mutagenesis studies in D. melanogaster led to the isolation of two neonicotinoid-
resistant strains that had lesions in the Dmα1 and the Dmβ2 genes, respectively 
(Perry et al. 2008). The combined data of our current and earlier studies suggest that 
insect α1 may play a central role in neonicotinoid insecticide action. 
In order to obtain a more detailed picture about the structural requirements for 
agonist action on Lcα1 and Lcα2-containing nAChRs, a collection of 13 close 
derivatives of the natural ligand ACh was assembled (Fig. 6). ACh and five 
derivatives (1, 4, 9, 10, 12, 13) could be purchased, while eight further compounds 
(2, 3, 5, 6, 7, 8, 11, 14) were synthesized in this study. Five centres for derivatization 
of ACh were chosen: first, one methyl group (R1) of the quaternary ammonium group 
was replaced by ethyl (2) and n-propyl (3). The ethylene group was substituted by 
methyl either in the α-(R2) or in the β-position (R3) yielding rac-α-methylcholine (5) 
and rac-β-methylcholine (4), respectively. The choline oxygen (X) experienced the 
most modifications: replacement of the oxygen by sulphur led to acetylthiocholine (9), 
while replacement by a methylene group yielded trimethyl-(4-oxopentyl)-ammonium 
(6). Homologation of the ethylene group by one carbon led to acetylhomocholine 
(11), while replacement of the acetyl group by -H or by -PO3
2- led to choline (12) and 
phosphocholine (13), respectively.  Inversion of the ester function in ACh led to the 
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Figure 6: Chemical structures of acetylcholine (ACh) backbone derivatives for nAChR structure-activity 
relationships and of nicotinoids and imidacloprid. (A) Overview of ACh modifications. (B) Chemical structures: 
(1) ACh; (2) acetyl-N-ethylcholine; (3) acetyl-N-propylcholine; (4) acetyl-β-methylcholine; (5) acetyl-α-
methylcholine; (6) trimethyl-(4-oxopentyl) ammonium; (7) trimethyl-ethoxyethyl ammonium; (8) trimethyl-
pentyl ammonium;  (9) acetyl-thiocholine; (10) carbamoylcholine; (11) acetyl-homocholine; (12) choline; (13) 
phosphocholine; (14) trimethyl-(3-methoxy-3-oxopropyl) ammonium; (15) (-)-nicotine; (16) (1R,2R,4S)-(+)-6-(6-
chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane, epibatidine; (17) imidacloprid. From Dederer et al. 2013.   
methyl ester (14). Reduction of the ester carbonyl oxygen in ACh (X) led to the 
choline ethyl ether (7), while simultaneous replacement of the ether oxygen by 
methylene resulted in trimethyl-pentyl ammonium (8). Replacing the acetyl methyl 
group in ACh (R4) by amino led to carbamoylcholine (10). The nAChR agonistic 
potential of this collection was analysed on the insect α subunit-containing 
Lcα1/Ggβ2 and Lcα2/Ggβ2, and in comparison, on the chicken neuronal receptor 
Ggα4/Ggβ2. 
The most remarkable differences with respect to the EC50 values were seen for 
acetyl-N-ethylcholine (2), which was as potent or more potent on Lcα1/Ggβ2 and 
Lcα2/Ggβ2 as ACh, while the EC50 value of (2) on Ggα4/Ggβ2 rose almost by a 
factor of 1000 compared to ACh. This might point to different steric conditions at the 
binding site of the quaternary ammonium group in insect and mammalian nAChRs.    
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Similarly, the EC50s of acetyl-α-methylcholine (5) for Lcα1/Ggβ2 and Lcα2/Ggβ2 rose 
only moderately (factor 2.4) relative to ACh, while in the case of Ggα4/Ggβ2 the 
increase of EC50 for (5) was about 427-fold compared to ACh. In his review, Schmitt 
(2000) assumed that the α-methyl residue may interact at the same locus as the N-
methyl groups. Based on this explanation, our results of (5) might again indicate the 
steric differences of quaternary ammonium group binding sites in insect and 
mammalian nicotinic receptors. By contrast, methyl substitution in β-position affected 
the EC50 values on all three receptors dramatically. In the case of acetyl-β-
methylcholine (4), EC50 relative to ACh for Lcα1/Ggβ2 increased 287-fold, for 
Lcα2/Ggβ2 85-fold and for Ggα4/Ggβ2, the factor of increase was 830. The binding 
site conditions of insect, as well as vertebrate nAChRs apparently do not tolerate 
steric hindrance in β-position.                 
A third derivative where the difference in EC50 increases between insect and chicken 
receptors reached or exceeded the factor 100, was trimethyl-(3-methoxy-3-
oxopropyl) ammonium (14), which basically corresponds to ACh with inverted ester 
function. Here, the EC50s relative to ACh for Lcα1/Ggβ2 and Lcα2/Ggβ2 increased by 
modest 4.3 and 6.7-fold, while in the case of Ggα4/Ggβ2, this factor was 405. One 
explanation for these differences could be that the choline oxygen might perhaps 
play a bigger role in agonist binding of vertebrate than in insect nAChRs. Also it is 
possible that the carbonyl oxygen in inverted position encounters more steric 
hindrance in the binding pocket of vertebrate than of insect nAChRs.  
Amongst the derivatives with less pronounced receptor potency differences, for 
acetylhomocholine (11) a dramatic increase of EC50 was noted for Ggα4/Ggβ2 
(~550-fold) relative to ACh, while for the insect receptors Lcα1/Ggβ2 and Lcα2/Ggβ2, 
this was a more moderate 24-fold and 31-fold, respectively. Also trimethyl-(4-
oxopentyl) ammonium (6) retained much of the ACh potency in Lcα1/Ggβ2 and 
Lcα2/Ggβ2 with EC50 increases of 6.3 and 2.4, respectively, relative to ACh, while 
the chicken receptor potency dropped by a factor of 89. Presumably, the binding site 
part of the two insect nAChRs addressing the area between the quaternary 
ammonium group and the ester function might be more tolerant to the chain length 
between these groups than the vertebrate nAChRs. Also, like in the case of (14), the 
choline oxygen is likely to be more important in interaction with the binging site of 
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mammalian than insect nAChRs. For all other derivatives differences of EC50 losses 
between the three receptor forms relative to ACh were generally near or below factor 
10, which made these derivatives less instructive.  
Structure-activity and structure-selectivity studies for agonist action on native and 
recombinant insect nAChRs have focussed in the past on neonicotinoid derivatives 
(Ihara et al. 2003, Millar and Denholm 2007, Shimomura et al. 2004, Thany et al. 
2007, Tomizawa and Casida 2003, 2005, 2009) and on spinosyns (Baxter et al. 
2010, Kirst 2010, Perry et al. 2007, Sparks et al. 2001). By contrast, to our 
knowledge, systematic structure-activity relationships for the natural ligand ACh as 
lead structure have not been reported for insect nAChRs.  
In one study not published in a peer-reviewed journal, Schmitz (2002) systematically 
rigidized the lead structure of ACh upon 6 different structure types according to 
ligand classification of Schmitt (2000), and electrophysiologicaly tested these 
derivatives in structure-activity studies in Xenopus oocytes on four rat receptors: 
neuronal α3/β4, α4/β2 and α7, as well as muscular nAChR. The results of the rat 
α4/β2 receptor could be comparable with those of the chicken Ggα4/Ggβ2 since 
other studies could not show significant differences in sensitivity to nicotinoids and 
neonicotinoids between these two receptors (D’Amour and Casida 1999, Tomizawa 
et al. 2001, 2005). Schmitz (2002) investigated the effect of extension of the alkyl 
chain at the ACh quaternary ammonium and found out that the replacement of one 
methyl group by ethyl – independent of other structural changes of ACh – led to the 
loss of activity on rat α4/β2 receptor and significant decrease of activity on other rat 
neuronal receptors. Additionally, from the ACh derivatives reported by Schmitz 
(2002), acetyl-α-methylcholine and acetyl-β-methylcholine were electrophysiologically 
tested in oocytes on α4/β2. Schmitz (2002) observed that substitution in β-position 
affected the agonist potencies of derivatives: neither acetyl-β-methylcholine nor other 
β-substituted derivatives – independent from the length of substitution – were active 
on rat neuronal receptors. These results on rat α4/β2 receptor might confirm our 
finding about steric conditions at the binding site in vertebrate nAChRs. In addition to 
rac-acetyl-α-methylcholine, Schmitz (2002) also tested (R)-acetyl-α-methylcholine 
and (S)-acetyl-α-methylcholine and found that the (S)-enantiomer has two times 
lower activity on rat α4/β2 than the racemate, whereas the antipode was inactive on 
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that receptor. The higher activity of the racemate was explaned with the synergetic 
action of the two enantiomers (Schmitz 2002). Furthermore, acetyl-α-dimethylcholine 
was also found to be inactive on rat α4/β2 receptor (Schmitz 2002). Schmitt (2000) 
implied that the α-methyl residue of ACh derivatives may interact at the same locus 
in the binding site as the N-methyl groups. Additionally, the substitution on α position 
is demonstrated to be stereosensitive (Schmitt 2000).     
In general, it appears that Ggα4/Ggβ2 is much less forgiving to the moderate 
structural changes on ACh that are displayed by the derivatives investigated in this 
study. EC50 increases were generally 2-3 orders of magnitude, except for the very 
close derivatives acetylthiocholine and carbamoylcholine. By contrast, the less 
dramatic or non-existent EC50 rises for the insect receptors Lcα1/Ggβ2 and 
Lcα2/Ggβ2 suggest that particularly substitution at the ACh quarternary ammonium, 
branching and the length of the ACh alkyl chain between ammonium and ester 
function, ketone analogs of ACh as well as the inverted ACh ester structure could be 
sources for selectivity between insect and chicken nAChRs investigated in this study 
and therefore logical entry points for derivatization programs. 
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Abstract: 
Nicotinic acetylcholine receptors (nAChRs) are the binding sites for nicotinoid 
drugs, such as nicotine and epibatidine, and are the molecular targets of the 
selectively insecticidal neonicotinoids. In this study we report the full length cDNA 
cloning of the three Ctenocephalides (C.) felis (cat flea) nAChR α subunits Cfα1, 
Cfα2, and Cfα3. When expressed in Xenopus oocytes as hybrid receptors with the 
Gallus gallus (chicken) β2 (Ggβ2) subunit, these cat flea α subunits formed 
acetylcholine-responsive ion channels. Acetylcholine-evoked currents of Cfα2/Ggβ2 
were resistant to α-bungarotoxin, while those of Cfα1/Ggβ2 were sensitive to this 
snake toxin. The pharmacological profiles of Cfα1/Ggβ2, Cfα2/Ggβ2 and the chicken 
neuronal receptor Ggα4/Ggβ2 for acetylcholine, two nicotinoids and 6 insecticidal 
neonicotinoids were determined and compared. Particularly remarkable was the 
finding that Cfα1/Ggβ2 was far more sensitive to acetylcholine, nicotine and 
neonicotinoid agonists than either Cfα2/Ggβ2 or Ggα4/Ggβ2:  for the anti flea 
neonicotinoid market compound imidacloprid the respective EC50s were 0.02 µM, 
1.31 µM and 10 µM. These results were confirmed for another insect species, 
Drosophila melanogaster, where the pharmacological profile of the Dmα1 and Dmα2 
subunits as hybrid receptors with Ggβ2 in Xenopus oocyte expressions resulted in a 
similar sensitivity pattern as those identified for the C. felis orthologs. Our results 
show that at least in a Ggβ2 hybrid receptor setting, insect α1 subunits confer higher 
sensitivity to neonicotinoids than α2 subunits, which may contribute in vivo to the 
insect-selective action of this pesticide class.   
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1. Introduction 
Nicotinic acetylcholine receptors (nAChRs) are ligand-controlled cation 
channels, that act in fast neurotransmission at cholinergic synapses in vertebrates 
(Dolly and Barnard 1984, Galzi et al. 1991, Corringer et al. 2000, Kalamida et al. 
2007) and invertebrates (Jones and Sattelle 2004, Jones et al. 2007, Thany et al. 
2007). They belong to the cysteine (Cys) loop ligand-gated ion channel (LGIC) 
superfamily and form pentamers of subunits, each of which consists of a N-terminal 
Cys loop-containing ligand-binding extracellular domain, four transmembrane helices 
and a C-terminus facing the extracellular space (Sine and Engel 2006). Two vicinal 
cysteine residues in the extracellular domain, which are involved in acetylcholine 
(ACh) binding, define nAChR α subunits in all species, while non-α subunits (β, γ, δ 
or ε) lack this motif (Ortells and Lunt 1995, Le Novere and Changeux 1995, Karlin 
2002, Connolly and Wafford 2004, Barry and Lynch 2005). 
In mammals, seventeen nicotinic acetylcholine receptor subunits (α1-α10, β1-
β4, γ, δ, ε) coassemble into mostly heteropentameric, sometimes homopentameric, 
nAChRs that are present at the skeletal neuromuscular junction, the autonomic 
ganglia and the central nervous system (Millar and Gotti 2009, Albuquerque et al. 
2009). In humans, nAChRs represent valuable drug targets to treat disorders ranging 
from neuropathic pain, Alzheimer’s disease and schizophrenia to depression and 
tobacco addiction (Jensen et al. 2005, Livett et al. 2006, Taly et al. 2009, D’hoedt 
and Bertrand 2009).  
Insects possess fewer nAChR subunit genes than mammals, with e. g. 10 
genes in Drosophila (D.) melanogaster (Dmα1-Dmα7, Dmβ1-Dmβ3, Littleton and 
Ganetzky 2000, Sattelle et al. 2005) and Anopheles (A.) gambiae (Agα1-Agα9, Agβ1, 
Jones et al. 2005), 11 genes in Apis (A.) mellifera (Amα1-Amα9, Amβ1-Amβ2, Jones 
et al. 2006), and 12 genes in Bombyx mori (Bmα1-Bmα9, Bmβ1-Bmβ3, Shao et. al. 
2007). In further contrast to mammals, the expression of functional nAChRs in 
insects appears to be restricted to the central nervous system (Sattelle 1980, Breer 
and Sattelle 1987). Nicotinic acetylcholine receptors are targets for different classes 
of insecticides, such as nicotine, spinosyns or nereistoxin analogs (Millar and 
Denholm 2007). The by far largest and commercially most important insecticide class 
addressing nAChRs are the neonicotinoids (Fig. 1), that have entered the market as 
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pesticides in 1991 and have experienced a fast growth in sales (Millar and Denholm 
2007, Jeschke and Nauen 2008). It has been shown by electrophysiological 
experiments on nerve preparations from D. melanogaster, Periplanata americana, 
Apis mellifera and Heliothis virescens (Brown et al. 2006, Tan et al. 2007, Thany et 
al. 2007), that neonicotinoids such as imidacloprid or clothianidin (Fig. 1) act as 
partial or full agonists in an in vivo setting. The low toxicity of neonicotinoids to 
mammals has been explained by their rather poor agonist action on most mammalian 
nAChRs, as opposed to their strong agonist potency on insect nAChRs (Tomizawa 
and Casida 2003, 2005, 2009; Matsuda et al. 2001, 2005, 2009).  
The molecular definition of the neonicotinoid target(s) in insects has been 
hampered by the difficulty of heterologous functional expression of insect nAChRs. 
Successful examples are largely limited to the formation of trans-species hybrid 
heteropentamers of insect α subunits with either chicken or rat β2 subunits (Millar 
1999, 2009). Xenopus oocyte expression and electrophysiology experiments with 
hybrid nAChR consisting of D. melanogaster Dmα2 and chicken β2 (Ggβ2) subunits 
suggested partial agonist activity of imidacloprid and super-agonist activity of 
clothianidin (Matsuda et al. 1998, Ihara et al. 2004). A comparative Xenopus oocyte 
electrophysiology study confirmed for Dmα2/Ggβ2 hybrids the partial agonist activity 
of imidacloprid and demonstrated the full agonist activity of nitenpyram. By contrast, 
only nitenpyram proved to be a partial agonist for Dmα1/Ggβ2, while imidacloprid 
showed no agonist activity in this receptor combination (Ihara et al. 2003). 
Radioligand binding experiments on diverse Myzus persicae α (Mpα) subunits 
coexpressed with rat β2 subunit in D. melanogaster S2 cells showed high affinity of 
[3H]imidacloprid for the rat β2 combinations with Mpα2 and Mpα3, but not Mpα1 and 
Mpα4 (Huang et al. 1999). Similar radioligand binding studies in S2 cell as well as 
Xenopus oocyte electrophysiology studies of rat β2 subunit coexpression 
experiments with Nilaparvata (N.) lugens α (Nlα) subunits showed that Nlα1/rat β2 
forms a high affinity receptor, Nlα2/rat β2 a low affinity receptor, while Nlα3/rat β2 or 
Nlα4/rat β2 constitute no neonicotinoid receptors (Liu et al. 2005, 2006, 2009). 
Xenopus oocyte coexpression of Nlα8 with rat β2 yielded also a low affinity 
neonicotinoid-gated ion channel, whose affinity could be increased 40-fold by 
coassembly with Nlα3 (Yixi et al. 2009). Sequence analyses on neonicotinoid-
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resistant insect mutants and heterologous expression of the mutated gene products 
have implicated amino acid exchanges in the insect α1 subunit (N. lugens, Liu et al. 
2005; D. melanogaster, Perry et al. 2008), the α3 subunit (N. lugens, Liu et al. 2005) 
and the β2 subunit (D. melanogaster, Perry et al. 2008) as potential causes for 
neonicotinoid resistance. However, taken together, the available data on insect 
nicotinic receptor neonicotinoid interactions within and between different species 
cannot easily be aligned and remains contradictory. 
The insect veterinary parasite Ctenocephalides (C.) felis (cat flea) is a major 
source of discomfort to cats and dogs and their owners, which leads to expenditures 
well over 2 billion US$ annually for control measures. Neonicotinoids, specifically 
imidacloprid, nitenpyram and dinotefuran (Fig. 1), are main weapons to combat cat 
fleas (Rust and Dryden 1997, Rust 2005). Given the economic importance of cat 
fleas, it is surprising that only a single report on the potential molecular target(s) of 
neonicotinoids in C. felis has been published. Bass et al. (2006) have reported the 
partial gene cloning, largely of the extracellular domains, of 8 nicotinic receptor 
subunits from C. felis (Cfα1-Cfα4, Cfα7, Cfα8, Cfβ1). Chimeric receptors of the 
ligand binding domains of Cfα1, Cfα2, Cfα3, Cfα7 and Cfβ1 with the D. melanogaster 
Dmα2 endoplasmic reticulum import signal sequence, transmembrane helices and C-
terminus were coexpressed with rat β2 subunitin S2 cells and investigated by 
[3H]imidacloprid ligand binding studies. The two functional combinations containing 
Cfα1 and Cfα3 sequences did bind the radioligand with high affinity (Bass et al. 
2006).  
In this study, we have identified the full length cDNA sequences of the Cfα1, 
Cfα2 and Cfα3 genes and we have cloned the genes for their D. melanogaster 
orthologs Dmα1, Dmα2 and Dmα3, as well as chicken α4 (Ggα4) and β2 (Ggβ2). We 
have demonstrated the functional coexpression of all these subunits with chicken β2 
in Xenopus oocytes in two electrode voltage clamp experiments. In Xenopus oocytes 
coexpressing Cfα1/Ggβ2, Cfα2/Ggβ2, Dmα1/Ggβ2, Dmα2/Ggβ2, and, for 
comparison, the chicken CNS nicotinic acetylcholine receptor Ggα4/Ggβ2, agonist 
properties, effective concentrations 50% (EC50) values and the electric current signal 
strength relative to that elicited by ACh (Imax[%ACh]) were determined for the natural 
ligand ACh, for the nicotinoids nicotine and epibatidine, as well as for the 
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neonicotinoids imidacloprid, nitenpyram, acetamiprid, thiacloprid, dinotefuran and 
clothianidin (compare Fig. 1). Furthermore, the antagonist properties of α-
bungarotoxin on these nAChR combinations were investigated. Our results suggest 
that the α1 subunits of both insects in hybrid receptors with chicken β2 confer far 
higher sensitivity to neonicotinoid agonist action than their insect α2 counterparts. 
 
Figure 1: Chemical structures of nicotinoids and neonicotinoids applied in this study. 
 
 
2. Materials and Methods 
2.1 Bacterial strains, plasmids, chemicals and insects. 
Bacterial cultures were grown in Luria-Bertani (LB) medium modified with 
supplements as required by the bacterial background and the introduced resistance 
genes. Polymerase chain reaction (PCR) products were cloned into pCR2.1-Topo, 
introduced into Escherichia (E.) coli Top10 cells (Invitrogen) and subcloned into the 
mammalian expression vector pcDNA3.1(+) (Invitrogen). Acetylcholine (ACh), 
nicotine and epibatidine were from Sigma. Imidacloprid (Dr. Ehrenstorfer), 
nitenpyram, thiacloprid (Riedel-de Haen) acetamiprid (Annopol), and dinotefuran 
(Nissan) were from external sources, clothianidin was provided by Intervet 
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Singapore. C. felis adult fleas (adapted to artificial feeding, Wade & Georgi, 1988) 
used in this study were collected from long term cultures maintained at Intervet 
Innovation GmbH, Schwabenheim, Germany. 
 
2.2 Identification, isolation and phylogenetic analysis of nicotinic acetylcholine 
receptor subunit genes from chicken, D. melanogaster and C. felis  
Total RNA was extracted from D. melanogaster imagoes, from C. felis flea 
imagoes and from freshly prepared chicken brain by a modification of the 
guanidinium thiocyanate/phenol extraction method (Chomczynski and Sacchi, 1987; 
Trizol, Sigma). Other molecular biology techniques were performed essentially as 
described by Sambrook and Russell (2001). Reverse transcription (RT-) PCR was 
performed using the Titan one tube RT-PCR system (Roche) with total RNA (0.5 – 1 
µg/50 µl) as template. In some cases, reverse transcription of total RNA was 
performed in a separate step followed by PCR under various conditions. 
The chicken nicotinic acetylcholine receptor subunit genes α4 and β2 (Ggα4, 
Ggβ2) were isolated by RT-PCR with chicken brain total RNA as template and the 
primer pairs 
GGGTACCATGGGATTTCTCGTGTCGAAGGGAACC/GGCGGCCGCTTAGATCATT
CCTGCCAGCCACGG and 
GGAATTCGGTACCATGGCGCTGCTCCGCGTCCTCTGCC/GAAGCTTATTTGGAG
GTGGGGGTGCCCTG, respectively. 
In the case of the D. melanogaster nicotinic acetylcholine receptor subunit 
genes α1, α2 and α2 (dmα1, dmα2, dmα3), the primer pairs 
CCCGGGTACCATGGGTAGCGTGCTATTCGCAG/CTTAAGCTTCTATAAGGTGTTC
TCGCTGCC, 
CCCGGGTACCATGGCTCCTGGCTGCTGCACC/CTTAAGCTTTAATTCTTCTTCTC
GGTTAGATTG and 
CTGGATCCGGTACCATGAAGTGGTTTCAAGTGACCATAG/CTAAGCTTACAACAC
GGGCCTGGCCAC, respectively, were used in RT-PCRs with fly imago total RNA as 
template. The PCR products obtained in these reactions were cloned into pCR2.1-
Topo and sequenced.  
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For the cloning of the genes encoding the nicotinic acetylcholine receptor subunits 
α1, α2 and α3 from C. felis (cfα1, cfα2 and cfα3), rapid amplification of cDNA ends 
was performed based on our own degenerate primer RT-PCR data (not shown) and 
on the published partial cDNA sequences DQ237865, DQ237866 and DQ237867 
(Bass et al. 2006). The missing cDNA sequences of cfα1, cfα2 and cfα3 were 
obtained by 3’-RACE (specific primers 
CGGGATCGATCTGCAGGATTACTACATCAG, 
GATATCTTGGGGGTCCCAGCCGAAAGGCATG, 
TGGGATATACTAGAAGTTCCGGCTGTCAGG, for cfα1, cfα2 and cfα3, respectively) 
and 5’-RACE (specific primers: CGGTGTGATGCAGAATCGCCTTCGTCATG, 
GATATCCCACTCTACACTGGGATAATACTCCCTC, 
CTTGACTGTGAGAGCGTCAGTAACATTCACC, for cfα1, cfα2 and cfα3, 
respectively) using total RNA from flea imagoes as templates and the SMART RACE 
cDNA Amplification Kit (Clontech) with generic flanking 5’- and 3’-RACE primer 
(Clontech), as outlined by the manufacturer. Based on the deduced start and stop 
codon positions in the 5’- and 3’-RACE product sequences, the PCR primers 
GCGGATCCAAAATGGAGAGCCTGTTACTGGCGCTC and 
GCAAGCTTTTATAGTTCCCCTGTGCCCATTTTAAGCAG for cfα1, 
CAGGTACCATGTATCTTACTAAATCTGCTCGG and 
CTCTCGAGTTATACATCTGGTAAAAACTGTTGTTGG for cfα2, as well as 
GAGGTACCATGAGGCTCCGTCCACCGGACG and 
GTCTCGAGTTATAGCTTGACATGTACATTAGC for cfα3, were then designed for 
the RT-PCR amplification of the full length genes from adult flea total RNA. The 
restriction enzyme sites introduced by the primers are underlined. The PCR products 
were cloned into pCR2.1-Topo and sequenced. Thereby, from the first RT-PCR 
amplification a 1747 bp PCR product with a 1728 bp open reading frame (cfα1) 
encoding C. felis nicotinic acetylcholine receptor subunit α1 (Cfα1) was identified, 
while the second RT-PCR yielded a 1702 bp PCR product with a 1686 bp open 
reading frame (cfα2) encoding C. felis nicotinic acetylcholine receptor subunit α2 
(Cfα2) and the third RT-PCR gave a 1918 bp PCR product with a 1902 bp open 
reading frame (cfα3) encoding C. felis nicotinic acetylcholine receptor subunit α3 
(Cfα3). Consensus sequences devoid of PCR errors were identified by sequencing of 
3 independent plasmid-cloned PCR fragments and direct PCR product sequencing 
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(cfα1 and cfα2), or 5 independent plasmid-cloned PCR fragments (cfα3), and by 
performing ClustalW alignments with the translated DNA sequences. ClustalW 
multiple sequence alignments of C. felis nicotinic acetylcholine receptor α subunits 
and other insect receptor subunits, the generation of phylogenetic trees and 
bootstrap analyses were done with in the DNAStar Lasergene software package. 
Bioinformatics analysis for the presence of endoplasmic reticulum import sequences 
and transmembrane helices were performed using SignalP3.0 
(http://www.cbs.dtu.dk/services/SignalP/) and TMHMM 
(http://www.cbs.dtu.dk/services/TMHMM-2.0/), respectively. 
 
2.3. Xenopus laevis oocyte expression and electrophysiology experiments with 
nicotinic acetylcholine receptor subunit genes from chicken, D. melanogaster 
and C. felis 
The open reading frames of Ggα4, Ggβ2, Cfα1-3 and Dmα1-3 were 
subcloned into pcDNA3.1(+) downstream of the T7 promoter via restriction enzyme 
sites introduced by the PCR primers. The resulting plasmids were linearized by Not I 
(Dmα1, Cfα1), Hind III (Cfα2, Cfα3), EcoR I (Ggβ2), Spe I (Dmα3) or Xba I (Dmα2, 
Ggα4), and in vitro transcription to obtain 5’-capped cRNA, and subsequent 
polyadenylation was performed using the mMESSAGE mMACHINE T7 transcription 
kit (Ambion) according to the manufacturers protocol. Transcripts were recovered by 
LiCl precipitation, dissolved in nuclease-free water at a final concentration of ~ 2 
µg/µl, and stored at -800C until use. 
 Defolliculated Xenopus laevis oocytes (sates V-VI) were purchased from 
Ecocyte Biosciences. 50.6 nl cRNAs were injected in a 1:1 molar ratio using a 
micromanipulator (World precision instruments). The oocytes were incubated for 48-
96 h at 170C in modified Barths solution (5 mM Hepes pH 7.2, 96 mM NaCl, 2 mM 
KCl, 1.8 mM CaCl2, 1 mM MgCl2, 2.4 mM Na-pyruvate, PS). Oocytes held in bath 
were perfused with Barths solution (5 mM Hepes pH 7.2, 96 mM NaCl, 2 mM KCl, 1.8 
mM CaCl2, 1 mM MgCl2) at a flow rate of approximately 1.8 ml/min were voltage 
clamped at – 60 mV using the two electrode clamp mode of an Turbo Tec-03x 
amplifier (NPI electronic). Electrodes were pulled from borosilicate glass (Science 
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products) using the Puller PC-10 (Narishige group), and filled with 3 M KCl. The 
electrode resistance ranged between 1-5 MΩ on the current-passing side. Agonist 
solutions, freshly prepared in Barths solution from dimethylsulphoxide- (DMSO-) 
dissolved stocks (10 mM – 500 mM), but not exceeding 1,5% (v/v) DMSO, were 
applied via bath perfusion for 30 sec. The resulting inward current was recorded 
using CellWorksLite 5.5.1 (NPI electronic), and analyzed later. An interval of 2 min 
was routinely maintained between agonist applications, which was elongated in some 
case to up to 10 min. Dose-response curves were analyzed using the Hill equation (I 
= Imax ([A]
nH/[A]nH + EC50
nH). Hereby “I” represents the current response measured at 
its peak, “Imax” the maximum response in the experiment, “EC50” the agonist 
concentration for 50% maximum response, and “nH” the Hill coefficient. and  
Calculations of these parameters as well as standard deviations (SD) and p values 
(Student’s t-test) were done using XL-fit (Microsoft®Excel™). For Imax[% ACh] 
determinations of nicotinoid and neonicotinoid agonists on different nAChR subunit 
combinations, a saturating ACh concentration was applied first, the maximum current 
recorded, and then saturating test agonist concentrations were applied. The 
percentage of maximum current (Imax[% ACh] ) relative to ACh was calculated. 
 
 
3. Results 
3.1 Isolation of chicken, D. melanogaster and C. felis genes encoding for 
nicotinic acetylcholine receptor subunits, and bioinformatic analysis. 
The chicken nicotinic acetylcholine receptor genes α4 and β2 (Ggα4, Ggβ2) 
were isolated from chicken brain total RNA by RT-PCR. Their deduced translation 
products were identical to the Genbank database sequences AJ250361 and 
AJ250362, respectively. For the PCR amplification of the D. melanogaster nicotinic 
acetylcholine receptor subunits α1, α2 and α3 (dmα1, dmα2, dmα3) total D. 
melanogaster RNA was used. The deduced translation product of dmα1 was 
identical to the Genbank sequence NM_079757 (Bossy et al. 1988, ALS) and the 
encoded polypeptide sequence of dmα2 proved to be identical to that of X53583 
(Sawruk et al. 1990, SAD). By contrast, the sequence of our dmα3 gene isolate 
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(submitted to Genbank with the accession number FR689750) contained, compared 
to Genbank-deposited dmα3 sequences (Y15593 and NM_080340; Schulz et al. 
1998), a deletion present in several independently isolated cDNA clones, that led at 
the protein level to the loss of a poly-alanine region predicted to be located in the 
second cytoplasmic loop. 
In case of C. felis, Genbank-deposited partial DNA sequences encoding the 
ligand-binding domains of the nicotinic acetylcholine receptor subunits α1, α2 and α3 
(cfα1, cfα2, cfα3) but lacking the sequences of the 5’-ends, the transmembrane 
domains and the 3’-ends (Bass et al. 2006) were used to design primers for 5’- and 
3’-RACE PCR experiments. Thereby, the missing 5’- (FR689741, FR689744, 
FR689747, respectively) and 3’-cDNA sequences (FR689742, FR689745, 
FR689748, respectively) of the C. felis α1-, α2- and α3-encoding genes were 
identified. Based on the deduced start and stop codon information, the full length 
genes (cfα1, cfα2, cfα3) of the three subunits were isolated by RT-PCR from C. felis 
total RNA. The first product cfα1 contained a 1728 bp open reading frame 
(FR689743). The deduced polypeptide sequence of this C. felis gene, Cfα1, showed 
extensive sequence identity to nicotinic receptor α-subunits from other insect 
species, particularly to A. gambiae α1 (80.4%, AY705394), D. melanogaster α1 
(79.8%, NM_079757), and A. mellifera α1 (77.0%, DQ026031). The RT-PCR product 
of cfα2 contained a 1686 bp open reading frame (FR689746). The deduced 
polypeptide sequence of this second C. felis α gene was highly homologous to α2 
subunits from A. gambiae α2 (84.9% identity, AY705395), A. mellifera α2 (83.9% 
identity, NM_001011625) and Tribolium (T.) castaneum α2 (83.1% identity, 
EF526081). The third full length C. felis α gene cfα3 encompassed a 1902 bp open 
reading frame (FR689749), and showed high sequence identity to α3 subunits from 
A. mellifera α3 (80.3%, DQ026032), T. castaneum α3 (78.7%, EF526082) and D. 
melanogaster α3 (73.3%, Y15593). More detailed polypeptide sequence 
comparisons, as illustrated in a multiple sequence alignment (Fig. 2) and the 
DNAStar/ClustalW-based molecular tree (Fig. 3) confirmed that cfα1, cfα2, cfα3 
belong to the insect nicotinic receptor subunit α1, α2 and α3 families, respectively.  
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 Inspection of the consensus sequence of the Cfα1-3 multiple sequence 
alignment (Fig. 2) revealed the presence of the cysteine loop and the loop A-C motifs 
typical for nicotinic receptor α subunit ligand binding sites within the putative 
extracellular domains in all three polypeptides (Arias 1997, Corringer et al. 2000, 
Albuquerque et al. 2009). These loops contained a number of highly conserved 
amino acid residues: within the cysteine loop the two cysteines corresponding to C128 
and C142 in the reference Torpedo α subunit, in loop A the amino acid residues 
corresponding to tryptophane W86 and tyrosine Y93, in loop B residues corresponding 
to W149 and Y151 and within loop C amino acids corresponding to C192 and C193 as 
well as Y190 and Y198 (all Torpedo α subunit numbering; Arias 1997, Corringer et al. 
2000, Albuquerque et al. 2009).  
 Kyte-Doolittle hydrophobicity plots of Cfα1-3 suggested the presence of an N-
terminal endoplasmic reticulum (ER) import signal sequence and of several 
transmembrane regions in all three polypeptide sequences (Fig. 4). Analysis of the 
three C. felis nicotinic receptor α subunit sequences with Signal P3.0 showed for 
Cfα1 an ER import signal sequence probability of 1.000 with a predicted cleavage 
site between A21 and N22, for Cfα2 a probability of 0.888 with a predicted cleavage 
site between C27 and N28, and for Cfα3 a probability of 0.996 with a predicted 
cleavage site between G29 and N30 (see Fig. 2). Further analysis of the Cfα subunit 
sequences identified in this study with the transmembrane helix detection program 
TMHMM predicted in all three gene products the four transmembrane helices typical 
for nicotinic acetylcholine receptor subunits and ligand-gated ion channels (LGIC) in 
general (Fig. 4; Arias 1997, Corringer et al. 2000, Albuquerque et al. 2009)). In the 
case of Cfα2, an additional transmembrane helix (T428-M450) not typical for LGICs 
was predicted (Fig. 4). Within and neighbouring to the second transmembrane 
helices TM2, the highly conserved amino acid residues of the nicotinic acetylcholine 
receptor ion channel ‘rings’ corresponding to D234, E237, S240, T244, L247, V251, L254 and 
E258 (chicken α7 subunit numbering, Corringer et al. 2000) are either also conserved 
in Cfα1-3, or replaced by structurally and/or functionally similar amino acids (Fig. 2; 
S240A, Cfα2; T244S, Cfα1-3; V251M, Cfα2, chicken α7 numbering, Corringer et 
al. 2000).  
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Figure 2: ClustalW amino acid sequence alignment of C. felis nAChR α subunits. Predicted ER import signal sequences (SS), 
the conserved extracellular loops (loop A, Cys loop, loop B, loop C) and the four predicted transmembrane helices (TM1-TM4) 
are highlighted by black bars under the consensus sequence. The predicted cleavage sites for the ER signal peptidase is 
indicated by an open triangle. The conserved tyrosine and tryptophane residues within the loop structures are marked with filled 
triangles, while the half-cystines of the Cys loops and the ligand binding sites are highlighted by connected open circles. The 
conserved amino acid residues forming the nAChR ion channel ‘ring’ in and near TM2 (Corringer et al. 2000) are highlighted by 
black circles (full conservation) or grey circles (partial conservation). 
 
Consensus #1 ...............L.............NP.AKRLYDDLLS.YN.L.RPV.N..D...VK..L.LSQLID.NLK.QI.TTN.W.E..W.D.K..W.P.. 
             ---------+----SS---+---------+---------+---------+---------+---------+---------+---------+---------+ 
                      10        20        30        40        50        60        70        80        90        100 
             ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
CfNicRa1.pro --------MESLLLALVATLAMASCGGMANPEAKRLYDDLLSNYNRLIRPVGNNSDRLTVKMGLRLSQLIDVNLKNQIMTTNVWVEQEWNDYKLKWNPDD        
92 
CfNicRa2.pro --MYLTKSARSAIQTLLVFLVLDLREVICNPDAKRLYDDLLSTYNRLIRPVSNNTDTVLVKLGLRLSQLIDLNLKDQILTTNVWLEHEWQDHKFQWDPTE        
98 
CfNicRa3.pro MRLRPPDAGTRALLALLVFILTAVAGCQGNPDAKRLYDDLLSNYNKLVRPVVNVTDALTVKIKLKLSQLIDVNLKNQIMTTNLWVEQSWYDYKLKWEPKE        
100 
 
Consensus #1 YGGV..L.VPS.HIW.PDIVLYNNADG...VT..TKA.L..TG.V.W.PPAI.KS.CEIDV.YFPFD.QTC.MKFGSWTYDG...DL.H........... 
             ---------+------ Loop A -----+---------+---------+---------+Cys loop-+---Loop B+---------+---------+ 
                      110       120       130       140       150       160       170       180       190       200 
             ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
CfNicRa1.pro YGGVDTLHVPSEHIWLPDIVLYNNADGNYEVTIMTKAILHHTGKVVWKPPAIYKSFCEIDVEYFPFDEQTCFMKFGSWTYDGYLIDLRHLQQTPDSDNID        
192 
CfNicRa2.pro YGGVTELYVPSEHIWLPDIVLYNNADGEYVVTTMTKAVLHHTGKVVWTPPAIFKSSCEIDVRYFPFDQQTCFMKFGSWTYDGDQIDLKHINQKLGDNKVE        
198 
CfNicRa3.pro YGGVEMLHVPSDHIWRPDIVLYNNADGNFEVTLATKATLNYTGRVEWRPPAIYKSSCEIDVEYFPFDEQTCVMKFGSWTYDGFQVDLRHRDEQTGSNVVD        
200 
 
Consensus #1 .GIDL...Y.SVEWDI..VPA.R.EK.Y.CC.EPY.DI.FNIT.RRKTLFYTVNLI.PC.GIS.L.VLVFYLP.DSGEK..L.ISILLS.T.FFLL..EI 
             ---------+---------+--------- Loop C --+---------+---------+TM1------+---------+---------+TM2------+ 
                      210       220       230       240       250       260       270       280       290       300 
             ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
CfNicRa1.pro VGIDLQDYYISVEWDIMRVPAVRNEKFYSCCEEPYPDIIFNITLRRKTLFYTVNLIIPCVGISFLSVLVFYLPSDSGEKISLCISILLSLTVFFLLLAEI        
292 
CfNicRa2.pro VGIDLREYYPSVEWDILGVPAERHEKYYPCCAEPYPDIFFNITLRRKTLFYTVNLIVPCVGISYLSVLVFYLPADSGEKIALCISILLSQTMFFLLISEI        
298 
CfNicRa3.pro IGIDLSEFYTSVEWDILEVPAVRNEKFYTCCDEPYLDITFNITMRRKTLFYTVNLIIPCMGISFLTVLVFYLPSDSGEKVSLSISILLSLTVFFLLLAEI        
300 
 
Consensus #1 IP.TSL..PLLGK..LFTM.L...S...T...LNV..R.P.TH.M.PWV...F...LP..L.M..P....D............................. 
             ---------+---------+---TM3---+---------+---------+---------+---------+---------+---------+---------+ 
                      310       320       330       340       350       360       370       380       390       400 
             ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
CfNicRa1.pro IPPTSLTVPLLGKYLLFTMMLVTLSVVVTIAVLNVNFRSPVTHKMAPWVHRLFVELLPKVLCMQRPKKD-DNGQDDTQDDRPSEVLTDVFHVPSEIDKYV        
391 
CfNicRa2.pro IPSTSLALPLLGKYLLFTMLLVGLSVVITIIILNVHYRKPSTHKMAPWVRKFFIKRLPKLLLMRVPK---DLLKDLAMNKIAGRGKKSKFSAALAAQQAH        
395 
CfNicRa3.pro IPPTSLVVPLLGKFVLFTMILDTFSICVTVVVLNVHFRSPQTHTMSPWVKRVFIHVLPRLLVMRRPHYPRDRRSGFASHRVMVRTCNGLEMRDSAAGPLG        
400 
 
Consensus #1 ................................G.P..........................................R..G.....G............. 
             ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
                      410       420       430       440       450       460       470       480       490       500 
             ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
CfNicRa1.pro PYGGK-----------------RFSADEFEIPGLPPLR--------------------YIQNSQVPTG---------RADGAGVVSGG-SPLHRLGCVED        
444 
CfNicRa2.pro AASGG-----------------SSPDSIRHMQGRPSGC--------------------NGLHTTTATN---------RFSGLVGALGG-G-IGGMG----        
443 
CfNicRa3.pro GTSAGGFSALGVEFTTRELEALSLTGSSCRIHGSPPLIPPSMLPPLPPPVLGVPPPPPNTMQPASPAEPGDVHVEDLRRTGNGSVSGSRTALHSHTATPA        
500 
 
Consensus #1 ............G.................................E..K.......I..H............DW..VAMVLDRLFLWIFT.A...GT.. 
             ---------+---------+---------+---------+---------+---------+---------+---------+---------+-----TM4-+ 
                      510       520       530       540       550       560       570       580       590       600 
             ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
CfNicRa1.pro EMFAD--AVNLDGATSGESNGPMDDDQCLDRESPVFDKPIVR----EMEKTIEGSRFIAQHVKNKDKFESVEEDWKYVAMVLDRLFLWIFTLACIGGTAL        
538 
CfNicRa2.pro -------GLGIGGGYNGLPSIMSGLDESLS--DVVPRKKYPF----ELEKAIHNVMFIQHHMLRQDEFNAEDQDWGFVAMVLDRLFLWIFTIASIVGTFA        
530 
CfNicRa3.pro HSHSTPGHQQANGAAAAPSTAAAGQPSSSTCEAQAMRALLHWHRCPELHKAMDGVTYIADHTRKEEESTRVKEDWKYVAMVLDRLFLWIFTLAVVVGTGG        
600 
 
Consensus #1 I...AP.LYD...PID...S..A..............- 
             ---------+---------+---------+-------- 
                      610       620       630           
             ---------+---------+---------+-------- 
CfNicRa1.pro IILQAPSLYDTTQPIDILYSKIAKKKLELLKMGTGEL.                                                                    
578 
CfNicRa2.pro ILCEAPALYDDTKPIDMELSSVAQQQFLPDV.                                                                            
562 
CfNicRa3.pro IILQAPTLYDDRVPIDVRLSEIASATANVHVKL.                                                                          
634 
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Figure 3: Phylogenetic dendrogram of insect nicotinic acetylcholine receptor subunits. The dendrogram (DNAStar) was 
derived from ClustalW-aligned protein sequences of Cfα1 (FR689743), Cfα2 (FR689746) and Cfα3 (FR689749) identified in this 
study together with the 10 D. melanogaster  subunits (Dmel-α1-α7, Dmel-β1-β3; accession No: NM_079757, X53583, Y15593, 
AJ272159, AF272778, AJ554209, AJ554210, NM_079203, NM_170147, NM_164386, respectively) and the α1-3 sequences of 
Anopheles gambiae (Agamb; accession No: AY705394, AY705395, AY705396, respectively), Apis mellifera (Amel; accession 
No: DQ026031, NM_001011625, DQ026032, respectively), Tribolium castaneum (Trib; accession No: EF526080, EF526081, 
EF526082, respectively) Nilaparvata lugens (Nlug; accession No: AY378698, AY378702, AY378700, respectively) and the α1-2 
sequences from Myzus persicae (Mper, accession No: X81887 and X81888, respectively). Furthermore, for reference, Gallus 
gallus (chicken) α4 and β2 (Gallus; accession No: AJ250361 and AJ250362, respectively) and Aplysia californica acetylcholine 
binding protein (Aplysia-AcChBP; accession No: AF322877) were included. D. melanogaster GABA-gated chloride channel 
(Dmel-rdl; accession No: M69057) served as an outgroup. 
 
 
 
Figure 4: Kyte-Doolittle hydrophobicity plots of Cfα1 (A), Cfα2 (B) and Cfα3 (C). The predicted ER import signal sequences 
(S), four predicted transmembrane helices (TM1-TM4) of Cfα1-3 and the predicted fifth transmembrane helix of Cfα2 (TM5) are 
indicated by underlying bars. 
 
Amino Acid Substitutions (x100)
0
172.5
20406080100120140160
20.2
94.4
35.9
94.0
99.4
83.3
99.9
87.0
76.2
65.3
43.9
100.0
99.3
73.0
79.4
98.7
83.1
100.0
80 .0
99.1
83 .2
5 7.5
90.7
80.4
97.0
100 .0
99 .7
71.5
Dmel-α2 (SAD)
Agamb-α2
Cfel-α2
Amel-α2
Tcas-α2
Nlug-α2
Nlug-α3
Dmel-α1 (ALS)
Agamb-α1
Cfel-α1
Amel-α1
Tcas-α1
Nlug-α1
Cfel-α3
Tcas-α3
Dmel-α3
Amel-α3
Agamb-α3
Dmel-α4
Dmel-β1
Gallus-β2
Gallus-α4
Dmel-α7
Dmel-α5 
Dmel-α6
Dmel-β3
Aplysia-AcChBP
Dmel-β2
Dmel-rdl
Mper-α1
Mper-α2
Insect
nAChR
α2 family
Insect
nAChR
α1 family
Insect
nAChR
α3 family
0
4.5
-4.5
0
4.5
-4.5
0
4.5
-4.5
25 50 75 100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 550 575
25 50 75 100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 550
25 50 75 100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 550 575 600 625
aa
aa
aaH
y
d
ro
p
h
o
b
ic
it
y
s
c
a
le
A
B
C
S
S
S TM1
TM1
TM1 TM4
TM2
TM2
TM4
TM2
TM3
TM3
TM3
TM4TM5 ?
H
y
d
ro
p
h
o
b
ic
it
y
s
c
a
le
Paper I 
 
62 
3.2. Functional studies by Xenopus laevis oocyte expression and voltage 
clamp electrophysiology with the specific ligand acetylcholine 
 To examine the functional properties of the full length Cfα1-3 cDNAs identified 
in this study, they were coexpressed with the chicken β subunit Ggβ2 (Bertrand et al. 
1994) and examined by two-electrode voltage clamp assays. In all three cases, 
application of ACh led to dose-dependent currents, which were rather weak in the 
case of Cfα3/Ggβ2, but strong in the case of Cfα1/Ggβ2 and Cfα2/Ggβ2 (Fig. 5A). 
This result confirmed that all three full-length C. felis cDNAs identified in this study 
encode functional α subunits. In the case of Cfα2/Ggβ2, the EC50 for ACh was 9.0 
µM with a Hill coefficient of 2.2, suggesting positive cooperativity (Fig. 5D, table 1). 
Cfα1/Ggβ2 was 2 orders of magnitude more sensitive to ACh activation (EC50 = 50 
nM, Fig. 5C, table 1), and a Hill coefficient of 1.03 suggested that this subunit 
combination does exhibit no cooperativity (table 1). For Cfα3/Ggβ2, an EC50 for ACh 
could not be determined in Xenopus two electrode voltage clamp experiments, due to 
the low signals, which also precluded detailed analysis of other agonists used in this 
study. A similar picture as for Cfα1-Cfα3 was seen in Xenopus two electrode voltage 
clamp experiments for the corresponding D. melanogaster orthologs: for 
Dmα2/Ggβ2, strong ACh-elicited currents and an EC50 of 6.6 µM were detected, with 
a Hill coefficient of 1.7 (table 2). The combination Dmα1/Ggβ2 also gave strong 
currents upon ACh exposure and proved to be much more sensitive than the Dmα2 
combination, with an EC50 of 70 nM and a Hill coefficient of 1.01 (table 2). By 
contrast, Dmα3/Ggβ2 gave only small ACh-dependent currents, precluding not only 
EC50 determination for this ligand, but also for other agonists used in this study (not 
shown). 
 Cfα2/Ggβ2 was insensitive to α-bungarotoxin at 2 µM (Fig. 5B), while ACh-
induced currents of the Cfα1/Ggβ2 combination were completely blocked by this 
concentration of snake toxin (Fig. 5B). Further experiments showed that the latter 
receptor is sensitive to much lower α-bungarotoxin concentrations, with 100 nM 
yielding > 60% blockage (data not shown). 
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Figure 5: Current responses of nAChRs in Xenopus oocyte two electrode voltage clamp experiments – ACh. (A) Cfα1, Cfα2 
and Cfα3. (B) α-bungarotoxin sensitivity of the ACh response of Cfα1 and Cfα2. (C) ACh titration of the current response of 
Cfα1. (D) ACh titration of the current response of Cfα2. 
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3.3. Comparative nicotinoid and neonicotinoid pharmacology of C. felis and D. 
melanogaster α1 and α2 hybrid receptors and G. gallus CNS α4/β2 receptor 
 Cfα2/Ggβ2 and Dmα2/Ggβ2:  all nicotinoid and neonicotinoid ligands (Fig. 
1) tested were agonists for this subunit combination in the µM concentration range. 
For all ligands clear dose-response relationships (see Fig. 6B, Fig. 7 A,B) could be 
documented and analyzed, with the exception of thiacloprid. The agonist potencies 
increased in the following order: dinotefuran < nitenpyram < nicotine ~ acetamiprid < 
clothianidin < imidacloprid < epibatidine (table 1). Imax determinations with ACh as 
standard showed that clothianidin behaved as a superagonist, dinotefuran and 
epibatidine as a full agonists, and all the other ligands were partial agonists, with 
acetamiprid being the least efficient (table 1). Like for the natural ligand ACh, the Hill 
coefficients for the two nicotinoids and 5 neonicotinoids were close to 2, which 
indicates positive cooperativity. Thiacloprid (Fig. 1) was also an agonist of 
Cfα2/Ggβ2, but EC50 or Imax values could not be determined, because in contrast to 
other neonicotinoids, repeated application of this derivative led to a continuous loss 
of signal, even at low concentrations (e. g. 1 µM, data not shown). The D. 
melanogaster ortholog Dmα2/Ggβ2 combination showed a similar picture as 
Cfα2/Ggβ2 for all ligands considered in both absolute (EC50) and relative potency, 
except for clothianidin, which had a 3-fold higher EC50 in the Drosophila receptor (5.5 
µM versus 1.65 µM, see table 2 in comparison with table 1, Fig. 7C,D). 
 Cfα1/Ggβ2 and Dmα1/Ggβ2:  the Cfα1/Ggβ2 hybrid subunit combination 
was also responsive to all nicotinoid and neonicotinoid ligands (Fig. 1) tested, but the 
sensitivity of this receptor to these agonists was generally one or two orders of 
magnitude higher compared to Cfα2/Ggβ2. Even low epibatidine (Fig. 6C) and 
thiacloprid (not shown) concentrations led to a persistent activation of Cfα1/Ggβ2, 
which precluded the determination of proper dose response curves. The EC50 values 
for nicotinoid and neonicotinoid ligands were generally in the nanomolar range, 
except for dinotefuran, whose EC50 was 4.19 µM, and showed an increase in potency 
with the order dinotefuran < nitenpyram < clothianidin < acetamiprid < nicotine < 
imidacloprid (table 1). Particularly potent was the insecticide imidacloprid, with an 
EC50 of 20 nM (table 1). The Hill coefficients were between 0.96 and 1.29, suggesting 
that none of the ligand-receptor interactions analyzed here displays pronounced 
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cooperativity. All nicotinoid and neonicotinoid ligands investigated here were partial 
agonists on Cfα1/Ggβ2 compared to the natural ligand ACh (table 1). Replacement 
of Cfα1 by its D. melanogaster ortholog Dmα1 in Xenopus expression and 
electrophysiology experiments revealed that Dmα1/Ggβ2 was persistently activated 
by epibatidine, and was also highly sensitive to nicotinoid and neonicotinoid agonists, 
with EC50 values and orders of potency similar to that of Cfα1/Ggβ2 (table 2). 
Imidacloprid was the most potent agonist with an EC50 of 40 nM (table 2, Fig. 7C). 
Different to Cfα1/Ggβ2 were the Hill coefficients, which were for the neonicotinoids 
between 1.18 and 1.64, suggesting some positive cooperativity (table 2). 
Ggα4/Ggβ2:  the chicken neuronal receptor Ggα4/Ggβ2 expressed in Xenopus 
oocytes showed an ACh response with an EC50 of 11.5 µM and some positive 
cooperativity (nH = 1.43), which is in line with the earlier report of Shimomura et al. 
(2004), while the nicotinoid nicotine gave an EC50 value of 760 nM (table 1). 
Epibatidine treatment led to persistent activation of Ggα4/Ggβ2 that could only 
insufficiently be washed off, which precluded EC50 determinations. Dose-response 
investigations of neonicotinoids on Ggα4/Ggβ2 in Xenopus oocytes showed that all 6 
compounds investigated were partial agonists in the µM to mM range, with 
Imax[%ACh] values from only 0.82% (nitenpyram) to 64.9% (clothianidin). EC50 
determinations showed that imidacloprid was 690-fold, nitenpyram 73-fold, 
acetamiprid 85-fold, dinotefuran 244-fold and clothianidin 142-fold less potent on the 
chicken receptor Ggα4/Ggβ2 than on Cfα1/Ggβ2, while loss of signal upon repeated 
exposure precluded EC50 determinations for thiacloprid (see table 1). 
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Table 1: Xenopus oocyte coexpression and electrophysiology of C. felis α1, C. felis α2 and chicken 
α4 with chicken β2: EC50, Hill coefficient nH and Imax 
 Cfα1/Ggβ2 Cfα2/Ggβ2 
 
Gaα4/Ggβ2 
 
 
EC50 
(µM) 
±SD 
nH ±SD 
Imax 
[% 
ACh]   
±SD 
EC50 
(µM) 
±SD 
nH ±SD 
Imax 
[% 
ACh]  
±SD 
EC50 
(µM)  
±SD 
nH ±SD 
Imax 
[% 
ACh]   
±SD 
ACh 
0.05 +/- 
0.01 
(n=6) 
1.03 +/- 
0.10 
(n=6) 
100 
9.0    +/- 
1.5 
(n=7) 
2.20 
+/- 0.22 
(n=7) 
100 
11.5 +/- 
3.5 
(n=4) 
1.43 +/- 
0.07 
(n=4) 
100 
Nic 
0.02 
+/- 0.00 
(n=5) 
1.33 
+/- 0.15 
(n=5) 
37.2* 
+/- 5.7 
(n=4) 
2.58 
+/- 0.46 
(n=5) 
1.68 
+/- 0.23 
(n=5) 
63.8§ 
+/- 5.8 
(n=6) 
0.76 
+/-0.13 
(n=2) 
1.1 
+/- 0.1 
(n=4) 
84.2# 
+/- 2.6 
(n=2) 
 
Epi n. d. n. d. n. d. 
0.009 
+/- 
0.001 
(n=4) 
1.64 
+/- 0.16 
(n=4) 
86.2§ 
+/- 7.5 
(n=6) 
n. d. n. d. 
n. d. 
 
 
Imi 
0.02 +/- 
0.00 
(n=5) 
1.29 +/- 
0.14 
(n=5) 
11.2* 
+/- 2.5 
(n=5) 
1.31  +/- 
0.35 
(n=6) 
1.81  +/- 
0.35 
(n=6) 
63.2§ 
+/- 4.2 
(n=2) 
13.8 
+/- 1..0 
(n=4) 
1.13 
+/- 0.04 
(n=4) 
24.8# 
+/- 9.05 
(n=4) 
Nit 
0.63 +/- 
0.22 
(n=5) 
1.26 +/- 
0.14 
(n=5) 
44.7* 
+/- 9.0 
(n=4) 
24.4  +/- 
6.4 
(n=6) 
2.12  +/- 
0.19 
(n=6) 
43.5§ 
+/- 1.2 
(n=2) 
45.8 
+/- 9.3 
(n=4) 
1.37 
+/- 0.07 
(n=4) 
0.82# 
+/- 0.27 
(n=3) 
Acet 
0.11 +/- 
0.05 
(n=5) 
1.04 +/- 
0.18 
(n=5) 
13.2* 
+/- 2.2 
(n=5) 
2.63  +/- 
0.26 
(n=4) 
1.61  +/- 
0.08 
(n=4) 
20§ 
+/- 3.9 
(n=2) 
9.4 
+/- 0.91 
(n=4) 
1.22 
+/- 0.06 
(n=5) 
5.01# 
+/- 0.52 
(n=6) 
Din 
4.19 +/- 
1.70 
(n=5) 
1.07 +/- 
0.16 
(n=5) 
34.2* 
+/- 6.8 
(n=5) 
124.8 
+/- 16.4 
(n=5) 
2.08  +/- 
0.12 
(n=5) 
94.4§ 
+/- 23.1 
(n=3) 
1021.4 
+/- 
120.8 
(n=5) 
1.71 
+/- 0.19 
(n=5) 
9.13# 
+/- 1.48 
(n=5) 
Clo 
0.15 +/- 
0.07 
(n=5) 
0.96 +/- 
0.08 
(n=5) 
44.3* 
+/- 5.2 
(n=4) 
1.65  +/- 
0.12 
(n=4) 
2.24  +/- 
0.13 
(n=4) 
148§ +/- 
0.6 
(n=2) 
21.3 
+/-2.3 
(n=3) 
1.6 
+/- 0.18 
(n=4) 
64.9# 
+/- 8.6 
(n=6) 
Imax[%ACh] was determined at the following saturating agonist concentrations: * nicotine 0.3 µM, imidacloprid 1 µM, nitenpyram 
5 µM, acetamiprid 2.5 µM, dinotefuran 20 µM, clothianidin 30 µM. § nicotine 15 µM, epibatidine 0.1 µM, imidacloprid 6 µM, 
nitenpyram 100 µM, acetamiprid 15 µM, dinotefuran 400 µM, clothianidin 30 µM. # nicotine 10 µM, imidacloprid 200 µM, 
nitenpyram 700 µM, acetamiprid 100 µM, dinotefuran 7 mM, clothianidin 200 µM. n. d. : not determined. Standard deviations 
(SD) are indicated. The EC50 differences between Cfα1/Ggβ2 and Cfα2/Ggβ2 were analysed by Student’s t-test for all agonists. 
The p-values for all pairs were below 0.0001. 
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Table 2: Xenopus oocyte coexpression and electrophysiology of D. melanogaster α1 and α2 with 
chicken β2: EC50, Hill coefficient nH and Imax 
 
 
Dmα1/Gaβ2 
 
Dmα2/Gaβ2 
 
EC50 (µM) 
±SD 
nH ±SD 
Imax [% ACh] 
±SD 
EC50 (µM) ±SD nH ±SD 
Imax [% ACh] 
±SD 
ACh 
0.07 +/-0.02 
(n=8) 
1.01 +/- 0.14 
(n=8) 
100 
6.6 +/- 1.4 
(n=5) 
1.70 +/- 0.13 
(n=5) 
100 
Epi 
n. d. 
 
n. d. n. d. 
0.003+/- 0,00 
(n=5) 
1.43 +/- 0,1 
(n=5) 
77.3§ +/- 6,4 
(n=6) 
Imi 
0.04 +/- 0.01 
(n=5) 
1.25 +/- 0.14 
(n=5) 
9.5* +/- 0,7 
(n=6) 
0.84 +/- 0.17 
(n=6) 
1.53 +/- 0.14 
(n=6) 
70.8§ +/- 7.2 
(n=5) 
Nit 
0.40 +/- 0.11 
(n=6) 
1.48 +/- 0.22 
(n=6) 
43.9* +/- 9.5 
(n=6) 
25.4 +/- 4.2 
(n=5) 
1.61 +/- 0.06 
(n=5) 
71.8§ +/- 11,1 
(n=4) 
Acet 
0.23 +/- 0.08 
(n=8) 
1.41 +/- 0.18 
(n=8) 
16.1* +/- 2.2 
(n=6) 
2.0 +/- 0.2 
(n=4) 
1.63 +/- 0.17 
(n=4) 
54.4§ +/- 1.2 
(n=3) 
Din 
4.56 +/- 1.06 
(n=7) 
1.64 +/- 0.26 
(n=7) 
39* +/- 0.8 
(n=6) 
105.7 +/- 8.5 
(n=5) 
1.94 +/- 0.21 
(n=5) 
101.2§ +/- 23.1 
(n=3) 
Clo 
0.34 +/- 0.08 
(n=8) 
1.18 +/- 0.29 
(n=8) 
34.2* +/- 5 
(n=6) 
5.4 +/- 1.3 
(n=6) 
1.51 +/- 0.17 
(n=6) 
113.8§ +/- 9.6 
(n=5) 
Imax[%ACh] was determined at the following saturating agonist concentrations: * imidacloprid 1 µM, nitenpyram 5 µM, 
acetamiprid 2,5 µM, dinotefuran 20 µM, clothianidin 30 µM. § epibatidine 0,05 µM, imidacloprid 6 µM, nitenpyram 100 µM, 
acetamiprid 15 µM, dinotefuran 330 µM, clothianidin 30 µM. n. d. : not determined. Standard deviations (SD) are indicated. The 
EC50 differences between Dmα1/Ggβ2 and Dmα2/Ggβ2 were analysed by Student’s t-test for all agonists. The p-values for all 
pairs were below 0.0001. 
 
Figure 6: Current responses of nAChRs in Xenopus oocyte two electrode voltage clamp experiments – examples of 
nicotinoids and neonicotinoids. (A) Nitenpyram (NIT) titration of the current response of Cfα1. (B) Nitenpyram (NIT) titration of 
the current response of Cfα2. (C) Current response of Cfα1 to epibatidine (EPI). (D) Epibatidine (EPI) titration of the current 
response of Cfα2.  
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Figure 7: Hill curves of various receptor combinations with neonicotinoids as agonists: (A) Cfα1/Ggβ2  (●), Cfα2/Ggβ2 (▲), 
and Ggα4/Ggβ2 (■):  titrations with imidacloprid;  (B) (A) Cfα1/Ggβ2 (●), Cfα2/Ggβ2 (▲), and Ggα4/Ggβ2 (■):  titrations with 
dinotefuran. (C) Dmα1/Ggβ2 (●), Dmα2/Ggβ2 (▲), and Ggα4/Ggβ2 (■):  titrations with imidacloprid;  (D) (A) Dmα1/Ggβ2  (●), 
Dmα2/Ggβ2 (▲), and Ggα4/Ggβ2 (■):  titrations with nitenpyram. The error bars indicate the SD from 4-6 data points. 
 
 
4. Discussion 
 In this study, we have isolated the full-length cDNAs encoding the nAChR 
subunits α1, α2 and α3 of the cat flea. In a previous study, the ligand binding 
domains of these three subunits were reported, and receptor chimera of Cfα1 and 
Cfα3 ligand binding domains with Dmα2 signal sequence, transmembrane helices 
and C-terminus were shown to form epibatidine and imidacloprid binding sites, when 
coexpressed with rat β2 in S2 cells (Bass et al. 2006). Here we have shown by 
Xenopus oocyte coexpression with the chicken β subunit Ggβ2 the 
electrophysiological functionality of all three full-length C. felis α subunit cDNAs. The 
ACh-evoked currents were in the µA range for Cfα1/Ggβ2 and Cfα2/Ggβ2, but in the 
low nA range for Cfα3/Ggβ2. The low currents precluded more detailed analysis of 
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the latter hybrid receptor by electrophysiological methods. We found that the 
combination Cfα2/Ggβ2 produces a hybrid receptor with an EC50 for its specific 
ligand ACh of 9 µM, a value similar to that determined for the chicken CNS receptor 
Ggα4/Ggβ2 (table 1). Cfα2/Ggβ2 is highly resistant to inhibition by α-bungarotoxin, 
as reported previously for the D. melanogaster ortholog (Bertrand et al. 1994). By 
contrast, the ACh EC50 of Cfα1/Ggβ2 was two orders of magnitude lower in the nM 
range, similar to that seen for Dmα1/Ggβ2 in this and in an earlier (Bertrand et al. 
1994) study. Furthermore, the ion channel of this hybrid receptor proved to be 
sensitive to α-bungarotoxin block.  
We first investigated the electrophysiology of Cfα2/Ggβ2 for two nicotinoids 
and 6 neonicotinoids, because in other insects hybrid receptors of the α2 subunits in 
combination with either rat or chicken β2 had been analysed as neonicotinoid binding 
sites and potential neonicotinoid targets by both electrophysiology and ligand binding 
experiments (Matsuda et al. 1998, Huang et al. 1999, Lansdell and Millar 2000, 
Nishiwaki et al. 2003, Ihara et al. 2003, Ihara et al. 2004, Shimomura et al. 2004, 
2005, Tomizawa et al. 2005). In our studies, by far the most potent ligand for 
Cfα2/Ggβ2 was the analgetic alkaloid epibatidine (Badio and Daly 1994), acting as a 
full agonist with an EC50 of ~ 9 nM, whereas nicotine and all neonicotinoids were 
partial agonists showing EC50s 2-4 orders of magnitude higher, in the µM range. 
Hereby, clothianidin acted as a superagonist, dinotefuran as full agonist, and all other 
neonicotinoids as well as nicotine as partial agonists of Cfα2/Ggβ2. While the EC50 of 
imidacloprid (1.31 µM, see Fig. 7A) on this potential neonicotinoid target was in an 
activity range that could perhaps be in agreement with its potent anti-flea activity, the 
potency of the other flea control market products nitenpyram (EC50 = 24.4 µM) or 
dinotefuran (EC50 = 124.8 µM, see Fig. 7B) appeared too low to explain their in vivo 
activity based on interaction with this receptor.  
Investigation of nicotinoid and neonicotinoid agonist potency on Cfα1/Ggβ2 
revealed that this hybrid receptor form is 10-100 times more sensitive to these 
ligands. Epibatidine activated this hybrid receptor persistently in the low nM range, 
while nicotine displayed an EC50 of 20 nM. All neonicotinoids investigated were 
partial agonists, that, except for dinotefuran (EC50 = 4.19 µM), showed EC50s in the 
nM range, with imidacloprid with 20 nM being the most potent representative. In 
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earlier electrophysiology studies on Drosophila α subunits (Ihara et al. 2003), the 
combination Dmα1/Ggβ2 has been reported as being non-responsive to imidacloprid 
and poorly responsive to nitenpyram (EC50 = 10 µM). The discrepancy of these 
earlier results to those of our C. felis nAChR study was puzzling to us, especially 
given the fact that the amino acid sequences of the ligand binding domains of Cfα1 
and Dmα1 are 96% identical. Therefore, we repeated and extended these earlier 
(Ihara et al. 2003) neonicotinoid Xenopus oocyte electrophysiology studies with 
hybrid receptors of both Dmα1 and Dmα2 (showing also 96% amino acid sequence 
identity to Cfα2 in the ligand binding domain) in combination with Ggβ2. In general in 
our study, the EC50 and Imax[%ACh] values for all ligands investigated and for both D. 
melanogaster hybrid nAChRs were highly similar to those obtained for the C. felis 
counterparts (compare table 1 with table 2). While for Dmα2/Ggβ2 our results for 
imidacloprid (EC50 = 0.84 µM, Imax = 71% versus the earlier results EC50 = 2.88 µM, 
Imax = 55%) and nitenpyram (EC50 = 25.4 µM, Imax = 72% versus the earlier results 
EC50 = 52.5 µM, Imax = 86%) were comparable to those of the previous study (Ihara et 
al. 2003), this was not the case for Dmα1/Ggβ2. In our hands, for Xenopus oocyte-
expressed Dmα1/Ggβ2, imidacloprid was an extremely potent partial agonist (EC50 = 
40 nM), followed by acetamiprid, clothianidin and nitenpyram, that also proved to be 
partial agonists with nM potencies (table 2, Fig. 7 C,D). We have no explanation for 
this discrepancy in results with respect to Dmα1/Ggβ2 between our study and that of 
Ihara et al. (2003), except that these authors used cDNA injection in a 1:1 ratio, while 
in our experiments cRNA 1:1 was employed. It is conceivable that cDNA injection 
leads to a different protein expression ratio of the two genes compared to cRNA 
injection, which may lead to distinct subunit stoichiometries that have been shown in 
other receptor systems to translate into different pharmacologies (Moroni et al. 2006). 
This possibility needs to be addressed in future experiments. 
Our electrophysiology comparisons of the C. felis and D. melanogaster α 
subunits (see Fig. 7, tables 1 and 2) suggest that the insect α1 subunit may be a 
better candidate for being a crucial part of the in vivo neonicotinoid target than insect 
α2, which has been in the center of many previous investigations. This notion is 
supported by a number of earlier and current studies: Huang et al. (1999) reported 
ligand binding studies in S2 cells on hybrid receptors of Myzus (M.) persicae α1 and 
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α2 with rat β2, respectively. These authors found that while both hybrid receptors 
showed binding of epibatidine, only M. persicae α2/ rat β2 was a high affinity receptor 
for imidacloprid. Historic nomenclature can be deceiving, however: protein sequence 
alignments (see Fig. 3) reveal, that imidacloprid-binding M. persicae α2 belongs to 
the insect α1 family, while M. persicae α1, reportedly with no imidacloprid-binding 
capacity (Huang et al. 1999), is a member of the insect α2 family (Fig. 3). Target site-
based neonicotinoid resistance has been reported for two different insect species, N. 
lugens (Liu et al. 2005) and D. melanogaster (Perry et al. 2008). In N. lugens, Y151S 
mutations have been identified in the nAChR subunits α1 and α3 that have been 
implicated in neonicotinoid resistance (Liu et al. 2005, 2006, 2009a,b; Yixi et al. 
2009, Li et al. 2010). Mutagenesis studies in D. melanogaster led to the isolation of 
two neonicotinoid-resistant strains that had lesions in the Dmα1 and the Dmβ2 
genes, respectively.  
Taken together, the combined data of our current and earlier studies suggest 
that insect α1 may play a central role in neonicotinoid insecticide action. However, 
there should be awareness that the majority of studies were and still are performed 
with trans-species hybrid receptors, as ‘insect-only’ nAChRs have not yet been 
reported in heterologous systems (Millar 1999, 2009), with the exception of a 
homomeric locust receptor (Marshall et al. 1990, Amar et al. 1995). So far, it is 
unknown whether expression system factors, such as growth temperature (Lansdell 
et al. 1997), as yet unrecognized missing subunits, or the need for specific folding 
factors, such as RIC-3 (Millar 2008) or Lynx (Liu et al. 2009b), perhaps not present or 
insufficiently present in the current expression systems, are responsible for this 
failure. Therefore, potentially fundamental effects of insect-derived cosubunits other 
than the ‘artificial’ chicken or rat β2 on specificity, potency and maximal currents of 
recombinant insect nAChRs cannot be ruled out. There is already evidence that the 
use of a single insect α subunit in the current and most previously reported 
expression systems is too simplistic: in D. melanogaster biochemical data support the 
association of Dmα3 and Dmβ1 (Chamaon et al. 2000) as well as Dmα1, Dmα2 and 
Dmβ2 (Chamaon et al. 2002) in flies in vivo, and evidence for coassembly of Dmα1, 
Dmα2 and Ggβ2 has been obtained in heterologous expression experiments in 
Xenopus oocytes (Schulz et al. 2000). More recently, functional coassembly of N. 
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lugens α1 and α2 with rat β2 (Liu et al. 2009a) as well as of N. lugens α3 and α8 with 
rat β2 (Yixi et al. 2009) was observed in Xenopus oocyte expression experiments. 
These studies were followed by experiments that suggested an in vivo assembly of 
N. lugens subunits α1 and α2 and β1 and α3, α8 and β1 in this planthopper species 
(Li et al. 2010).  
In summary, our hybrid receptor study provides evidence for a central role of the α1 
subunit for neonicotinoid action in C. felis and D. melanogaster, and possibly insects 
in general. More definitive conclusions have to await the definition and heterologous 
functional expression of ‘insect-only’ nAChRs that have so far been elusive, despite 
more than 20 years of intense efforts.  
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Abstract 
 
Insect nicotinic acetylcholine (ACh) receptors (nAChRs) are the targets of several 
insecticide classes. In the present study, we report the gene identification and cloning 
of nAChR α1 and α2 subunits (Lcα1 and Lcα2) from the sheep blowfly Lucilia 
cuprina. Xenopus oocytes voltage clamp experiments as hybrids with the chicken β2 
nAChR (Ggβ2) subunit resulted in ACh-gated ion channels with distinct dose–
response curves for Lcα1/Ggβ2 (effective concentration 50% [EC50] = 80 nM; nH = 
1.05), and Lcα2/Ggβ2 (EC50 = 5.37µM, nH=1.46). The neonicotinoid imidacloprid was 
a potent agonist for the α-bungarotoxin-sensitive Lcα1/Ggβ2 (EC50 ~ 20 nM), while 
the α-bungarotoxin-resistant Lcα2/Ggβ2 showed a 30-fold lower sensitivity to this 
insecticide (EC50 = 0.62µM). Thirteen close derivatives of  ACh were analysed in 
EC50, Hill coefficient and maximum current (relative to ACh) determinations for 
Lcα1/Ggβ2 and Lcα2/Ggβ2 and the chicken Ggα4/Ggβ2 nAChRs, and comparisons 
relative to ACh allowed the definition of novel structure-activity and structure-
selectivity relationships. In the case of N-ethyl-acetylcholine, the EC50 of the chicken 
Ggα4/Ggβ2 rose by a factor of 1000, while for both Lcα1/Ggβ2 and Lcα2/Ggβ2, 
potency remained unchanged. Further derivatives with insect nAChR selectivity 
potential were acetyl-α-methylcholine and trimethyl-(3-methoxy-3-
oxopropyl)ammonium followed by acetylhomocholine and trimethyl-(4-oxopentyl) 
ammonium. Our results may provide guidance for the identification or design of 
insect-specific nAChR agonists using structure-based or in silico methods. 
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Introduction 
The sheep blowfly Lucilia (L.) cuprina is the causative agent of major animal 
distress and economic losses in sheep husbandry in subtropical areas, such as 
Australia and South Africa. Disease is caused by the infestation of the living animal 
by L. cuprina larvae. This infestation is termed myiasis. Adult female flies lay eggs in 
the wool of sheep, particularly in humid parts affected by bacterial wool rot or by 
faecal and urine fleece soiling, a process called blowfly strike. Hatched larvae pass 
through three stages, initially feeding on nutrients within the fleece, then on 
epidermal tissue excised by secreted enzymes and by their mouthparts, and 
subsequently also on skin secretions provoked by this tissue damage (Hall & Wall, 
1995; Tellam & Bowles, 1997). Treatment and control of this painful and debilitating 
disease is necessary, both for reasons of animal welfare and because of the 
considerable economic losses it causes to the sheep industry, which amount to up to 
AUS$260 million in Australia alone (Sackett & Holmes, 2006).  
 Practical blowfly strike control measures include general sheep management 
practices aimed at lowering strike frequency such as pizzle dropping, mulesing, tail 
docking or crutching (Tellam & Bowles, 1997) and the use of fly baits and traps 
(Urech et al., 2004; Broughan & Wall, 2006).  Experimental approaches  that have 
been pursued include selection of naturally resistant sheep (O’Meara et al., 1992; 
Tellam & Bowles, 1997), vaccination approaches against sheep blowfly larvae 
(Bowles et al., 1996; Tellam & Eisemann, 1998) and fly population control by sterile 
male release technology (Scott et al., 2004), but the main form of sheep myiasis 
control is the use of insecticides or insect growth regulators applied by dipping, jetting 
or dressing (Tellam & Bowles, 1997; Rothwell, 2005; Plant & Lewis, 2011). 
 Insecticide classes currently applied in sheep husbandry to combat blowfly 
strike include organophosphates, pyrethroids, avermectins (ivermectin) and 
spinosyns (spinosad) that bind to acetylcholinesterase, voltage-gated sodium 
channels, glutamate-gated chloride channels and nicotinic acetylcholine (ACh) 
receptors (nAChRs) as molecular targets, respectively. These lead to paralysis and 
death of the parasite. Among growth regulators, triazines (cyromazine) and 
pyrimidines (dicyclanil) are in use against L. cuprina. These compound classes are 
not directly harmful to the adult flies, but interfere with cuticle formation and lead to 
inhibition of hatching and moulting of larvae; however, resistance development is a 
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major concern in blowfly control. Resistance was first documented for organochlorine 
and carbamate insecticides, which led, amongst other factors, to their discontinuation 
as products, while the efficacy of organophosphates has been severely compromised 
by widespread resistance amongst L. cuprina populations (Levot, 1995). A dramatic 
example in the last decade is the emergence of resistance to the growth regulator 
diflubenzuron (Levot & Sales, 2004), which has rendered this compound largely 
ineffective against blowfly larvae in Australia.  
The prime targets of insecticidal compounds are nAChRs. The fastest growing 
pesticide class, neonicotinoids (Gundelfinger, 1992; Millar & Denholm, 2007; Jeschke 
& Nauen, 2008), as well as spinosyns (Thompson et al., 2000; Sparks et al., 2001; 
Kirst, 2010) bind to these ion channels. The nAChRs are homo- or heteropentameric 
ligand-gated cation channels, whose domain structure is divided into an N-terminal 
Cys loop-containing ligand-binding extracellular domain, four transmembrane helices 
and a C-terminus facing the extracellular space, the hallmarks of the ligand-gated ion 
channel superfamily of proteins (Sine & Engel, 2006).  nAChRs act in fast 
neurotransmission at cholinergic synapses in vertebrates (Corringer et al., 2000; 
Kalamida et al., 2007) and invertebrates (Jones & Sattelle, 2004; Jones et al., 2007). 
In contrast to mammals, where various nAChR subtypes occur in the muscles, the 
ganglia and the brain (Albuquerque et al., 2009; Millar & Gotti, 2009), the expression 
of functional nAChRs in insects appears to be restricted to the central nervous 
system (Sattelle, 1980; Breer & Sattelle, 1987). 
Neonicotinoids act as partial, full and super-agonists of insect nAChRs and are 
broadly active and highly selective insecticides that are also used against 
cyclorrhaphan flies, such as fruit flies or nuisance flies (Nurita and Abu Hassan, 
2010, Raga & Eidi Sato, 2011). The nAChR subunits α1, α2, and possibly also α3 
and α8/β2 are implicated as potential molecular targets in various insects (Matsuda 
et al., 2001; Liu et al., 2005, 2006, 2009; Gao et al., 2007; Perry et al., 2008; Yixi et 
al., 2009; Li et al., 2010; Dederer et al., 2011), whereas spinosad appears to act on 
receptors containing nAChR subunit α6 (Perry et al., 2007; Baxter et al., 2010). While 
spinosad is an established blowfly insecticide (Levot et al., 2002), no compound of 
the neonicotinoid class is yet registered on the market for use against L. cuprina. 
Preliminary bioscreen experiments have shown that imidacloprid and nitenpyram 
have some efficacy in killing L. cuprina larvae (H. Williams and H. Zoller, MSD Animal 
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Health Innovation GmbH, unpubl. obs.), which prompted us to investigate the nAChR 
subunits of this important insect parasite as potential pesticide targets.  
In the present study, we report the gene identification and molecular cloning of 
the two L. cuprina nAChR subunits Lcα1 and Lcα2. Using co-expression with chicken 
nAChR β2 in Xenopus laevis oocytes, the functionality of the gene product is shown 
and the pharmacology of standard nAChR agonists and antagonists established. 
Chemical synthesis of eight non-commercial and purchase of five additional ACh 
analogues allows a pharmacological comparison with the chicken nAChR α4/β2. The 
results establish a distinct structure-activity relationship for agonist action on the 
blowfly α subunits vs. the chicken α4 subunit, which may aid in the identification of 
fly-specific compounds. 
 
 
 
 
Experimental procedures 
Bacterial strains, plasmids, chemicals and insects 
Bacterial cultures were grown in Luria-Bertani medium modified with 
supplements as required by the bacterial background and the introduced resistance 
genes. PCR products were cloned into pCR2.1-Topo, introduced into Escherichia coli 
Top10 cells (Invitrogen, Carlsbad, CA, USA) and, in some cases, subcloned into the 
mammalian expression vector pcDNA3.1(+) (Invitrogen). ACh, acetylthiocholine, 
nicotine and epibatidine were from Sigma (St Louis, MO, USA) and imidacloprid was 
from Dr. Ehrenstorfer. The L. cuprina flies used in this study were collected from 
long-term cultures maintained at Intervet Innovation GmbH, Schwabenheim, 
Germany, and displayed no known resistance to neonicotinoids, organophosphate or 
carbamate insecticides. 
 
 
Identification, isolation and phylogenetic analysis of nicotinic acetylcholine receptor 
subunit genes from Lucilia cuprina and chicken 
Total RNA was extracted from L. cuprina heads by a modification of the 
guanidinium thiocyanate/phenol extraction method (Chomczynski & Sacchi, 1987; 
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Trizol, Sigma). Other molecular biology techniques were performed essentially as 
described by Sambrook & Russell (2001). RT-PCR was performed using the Titan 
one tube RT-PCR system (Roche, Indianapolis, IN, USA) with total RNA (0.5–1 
µg/50 µl) as template. In some cases, RT of total RNA was performed in a separate 
step followed by PCR under various conditions. 
The chicken nAChR subunit genes α4 and β2 (ggα4, ggβ2) were described in 
Dederer et al., 2011. For the identification of nAChR genes of L. cuprina, degenerate 
primer pairs were constructed from the peptide sequences MKFGSW(S/T) and 
VEWD(L/M)(G/R)VPA, which are conserved in α1 and α2 subunits of many insect 
species (see also Fig. 1). The derived degenerate primer sequences were 
ATGAA(AG)TT(CT)GG(GATC)AG(CT)TGGAC and 
GC(GATC)GG(GATC)ACI(CT)(GCT)IA(AGT)(AGT)AT(AG)TCCCA(CT)TC. These 
primers were used in RT-PCRs with fly head total RNA as template. Two distinct RT-
PCR products arising from L. cuprina NicRα1 and NicRα2 sequences of the 
expected size (seq1 and seq2, 
ATGAAATTTGGCTCTTGGACTTATGATGGTTACATGGTCGATTTAAGGCATCTTA
AACAAACGCCAGATTCCGATAACATTGAAGTTGGCATTGACCTTCAGGACTATTA
TATATCAGTTGAATGGGATATCATGCACCGTACCCGC and 
ATGAAATTTGGATCGTGGACCTATGATGGCGATCAAATTGATTTAAAACATATTA
ATCAGAAAAATGACAAGGATAATAAAGTGGAAATTGGCATTGATTTACGTGAATA
TTATCCAAGTGTGGAATGGGATATATTCACCGTGCCCGC, respectively) were 
identified and the missing cDNA sequences of the two L. cuprina genes were then 
obtained by nested rapid amplification of cDNA ends (RACE) using total RNA from fly 
heads as template and the SMART RACE cDNA Amplification Kit (Clontech, 
Mountain View, CA, USA) with generic flanking 5′-  and 3′-RACE primer (Clontech), 
as outlined by the manufacturer. In the case of the L. cuprina NicRα1 gene, the 5′-
gene region and the start codon was identified by 5′-RACE (first specific primer 
CTGATATATAATAGTCCTGAAGGTCAATGC, second specific primer 
GATGCCTTAAATCGACCATGTAACCATC), and the 3′-gene region and the stop 
codon by 3′-RACE (first specific primer GGACTTATGATGGTTACATGGTC, second 
specific primer CATTGAAGTTGGCATTGACCTTCAGG). For the identification of the 
L. cuprina NicRα2 5’-region, a simple RACE PCR was sufficient, while for the 3′-gene 
region, a nested RACE PCR approach was used (5′-RACE: specific primer 
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CCATTCCACACTTGGATAATATTCACG; 3’-RACE: first specific primer 
GTGGACCTATGATGGCGATCAAATTG, second specific primer 
GACAAGGATAATAAAGTGGAAATTGGC). Based on the deduced start and stop 
codon positions in the 5′-  and 3′-RACE product sequences, the PCR primers 
CAGGTACCATGGGGAGCGTGCTGTTTGCAGCTG and   
GTGCGGCCGCCTATAAGTTCGTGTCGCTGCCCAT for L. cuprina nicotinic 
receptor α1 as well as CTGGTACCATGTCCGCCTTACACTACAAGTCGACAC and 
GAGCGGCCGCTTAGGATTTCTTTTCAGTTAGATTG for L. cuprina nicotinic 
receptor α2 were then designed for the RT-PCR amplification of the full length genes 
from fly head total RNA. The restriction enzyme sites introduced by the primers are 
underlined. The PCR products were cloned into pCR2.1-Topo and sequenced. 
ClustalW multiple sequence alignments of L. cuprina nAChR α subunits and other 
insect receptor subunits, the generation of phylogenetic trees and bootstrap analyses 
were performed with the DNAStar Lasergene software package. Bioinformatics 
analysis for the presence of ER import sequences and transmembrane helices were 
performed using SignalP3.0 (Bendtsen et al., 2004) 
(http://www.cbs.dtu.dk/services/SignalP/) and TMHMM 
(http://www.cbs.dtu.dk/services/TMHMM-2.0/), respectively. 
 
 
Xenopus laevis oocyte expression and electrophysiology experiments with nicotinic 
acetylcholine receptor subunit genes from Lucilia cuprina and chicken 
The ORFs of Ggα4, Ggβ2 (both from chicken, Dederer et al., 2011), Lcα1 and 
Lcα2 were subcloned into pcDNA3.1(+) downstream of the T7 promoter via 
restriction enzyme sites introduced by the PCR primers. The resulting plasmids were 
linearized by SpeI (Lcα1), HindIII (Lcα2), EcoRI (Ggβ2) or XbaI (Ggα4), and in vitro 
transcription to obtain 5′-capped cRNA, and subsequent polyadenylation was 
performed using the mMESSAGE mMACHINE T7 transcription kit (Ambion, Austin, 
TX, USA) according to the manufacturers protocol. Transcripts were recovered by 
LiCl precipitation, dissolved in nuclease-free water at a final concentration of ~ 2 
µg/µl, and stored at -80 °C until use. 
 Defolliculated Xenopus laevis oocytes (sates V-VI) were purchased from 
Ecocyte Biosciences (Castrop-Rauxel, Germany). 50.6 nl cRNAs were injected in a 
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1:1 molar ratio using a micromanipulator (World Precision Instruments, Berlin, 
Germany). The oocytes were incubated for 48–96 h at 17 °C in modified Barths 
solution (5 mM Hepes pH 7.2, 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 
2.4 mM Na-pyruvate, PS). Oocytes held in bath were perfused with Barths solution (5 
mM Hepes pH 7.2, 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2) at a flow 
rate of  ~1.8 ml/min were voltage clamped at  –60 mV using the two electrode clamp 
mode of an Turbo Tec-03x amplifier (NPI Electronic, Tamm, Germany). Electrodes 
were pulled from borosilicate glass (Science Products, Hofheim, Germany) using the 
Puller PC-10 (Narishige Group, Tokyo, Japan), and filled with 3 M KCl. The electrode 
resistance ranged between 1–5 MΩ on the current-passing side. Agonist solutions, 
freshly prepared in Barths solution from dimethylsulfoxide- (DMSO-) stock solutions 
(100 mM – 1 M), with final DMSO concentrations not exceeding 1,5% (v/v), were 
applied via bath perfusion for 30 sec. The resulting inward current was recorded 
using CellWorksLite 5.5.1 (NPI Electronic), and analysed later. An interval of 2 min 
was routinely maintained between agonist applications, which was elongated in some 
case to up to 5 min. Dose–response curves were analysed using the Hill equation (I 
= Imax ([A]
nH/[A]nH + EC50
nH), where “I” represents the current response measured at 
its peak, “Imax” the maximum response in the experiment, “EC50” the agonist 
concentration for 50% maximum response, and “nH” the Hill coefficient. Calculations 
of these parameters as well as standard deviations were carried out using XL-fit 
(Microsoft®Excel™). For Imax[% ACh] determinations of nicotinoid and neonicotinoid 
agonists on different nAChR subunit combinations, a saturating ACh concentration 
was applied first, the maximum current recorded, and then saturating test agonist 
concentrations were applied. The percentage of maximum current (Imax[% ACh]) 
relative to ACh was calculated. 
 
 
Synthesis of acetylcholine analogues 
General information: All commercially available chemicals were purchased 
from Sigma-Aldrich, except iodoethane and trimethylamine (Fluka, Buchs, 
Switzerland), sodium carbonate (Merck, Darmstadt, Germany) and (±)-2-
dimethylamino-1-propanol (ACC Corp., San Diego, USA). If not indicated the purity of 
chemicals was ≥98%. Anhydrous diethylether, acetone and ethanol were purchased 
from Acros Organics (Geel, Belgium). 1H-NMR spectra were obtained on a Bruker 
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DPX300 (300.13 MHz) spectrometer. Data are reported as chemical shifts (δ ppm) 
internally referenced to the solvent (D2O unless otherwise noted) and splitting 
patterns (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet). The purity and 
content of the synthesized products were determined using 1H-NMR quantification 
with maleic acid as internal reference. Water content of synthesized products was 
determined by Karl Fisher titration and found to be below 1% for all synthesized 
products. Syntheses were generally performed under an argon atmosphere. 
- 3-Acetoxypropyl(trimethyl)ammonium (acetylhomocholine) iodide (11) 
As outlined by Yamada et al. (1987) the synthesis was carried out according to the 
method of Renshaw et al. (1938) with some modifications. To a stirred solution of 3-
dimethylamino-1-propanol (1.2 ml, 10 mmol) in 50 ml anhydrous ether, acetyl 
chloride (0.7 ml, 10.2 mmol) was added drop-wise with ice cooling. Subsequently, the 
suspension was stirred for 20 h at room temperature. The resulting solid reaction 
product was isolated by filtration, dissolved in an aqueous 10 % sodium carbonate 
solution and extracted with ether. The ether extract was dried with MgSO4, filtered 
and the solvent was removed under reduced pressure. The resulting residue was 
stirred with 20 % molar excess of methyl iodide (0.7 ml, 11.1 mmol) in 50 ml 
anhydrous ether for 20 h at room temperature. The reaction mixture was filtered, the 
solid residue was washed with ether and dried under reduced pressure to yield 1.9 g 
(65% yield) of a solid. 1H-NMR δ 4.2 (t, 2H), 3.5 (m, 2H), 3.2 (s, 9H), 2.2 (m, 2H), 2.1 
(s, 3H). Content: 99.3% ± 0.4%.  
The compounds (2) (3) and (5) were synthesized according to the procedure for 
the synthesis of (11):  
- (2-Acetoxy-1-methyl-ethyl)-trimethyl ammonium (acetyl-α-methylcholine) 
iodide (5) 
Starting material: (±)-2-dimethylamino-1-propanol (1 g, 10 mmol), acetyl chloride (0.7 
ml, 10.2 mmol), methyl iodide (0.6 ml, 8.8 mmol). Product obtained as solid: 0.5 g 
(18% yield). 1H-NMR δ 4.5 (m, 2H), 3.9 (m, 1H), 3.2 (s, 9H), 2.2 (s, 3H), 1.5 (m, 3H). 
Content: 93.4% ± 0.8%.  
- 2-Acetoxyethyl-dimethyl-propyl-ammonium (acetyl-N-propylcholine) iodide (3) 
Starting material: 2-dimethylaminoethanol (5 ml, 50 mmol), acetyl chloride (3.7 ml, 51 
mmol), propyl iodide (5.2 ml, 53.8 mmol). Product obtained as solid: 1 g (7% yield). 
1H-NMR δ 4.5 (m, 2H), 3.7 (m, 2H), 3.4 (m, 2H), 3.2 (s, 6H), 2.2 (s, 3H), 1.8 (m, 2H), 
1.0 (t, 3H). Content: 94.3% ± 0.3%. 
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- 2-Acetoxyethyl-dimethyl-ethyl-ammonium (acetyl-N-ethylcholine) iodide (2) 
Starting material: 2-dimethylaminoethanol (5 ml, 50 mmol), acetyl chloride (3.7 ml, 51 
mmol), ethyl iodide (4.4 ml, 54.9 mmol). Product obtained as solid: 3.2 g (22% yield). 
1H-NMR δ 4.5 (m, 2H), 3.7 (m, 2H), 3.5 (q, 2H), 3.2 (s, 6H), 2.2 (s, 3H), 1.4 (t, 3H). 
Content: 99.3% ± 1.7%. 
- Trimethyl-(3-methoxy-3-oxopropyl) ammonium iodide (14)  
Methyl-3-(dimethylamino)-propionate (0.7 ml, 5 mmol) was stirred with methyl iodide 
(0.4 ml, 6 mmol) in 50 ml anhydrous ether for 20 h at room temperature. The product 
was isolated by filtration of the reaction mixture and drying under reduced pressure to 
yield 0.7 g of a solid (26% yield). 1H-NMR δ 3.8 (s, 3H), 3.7 (t, 2H), 3.2 (s, 9H), 3.0 (t, 
2H). Content: 97.2% ± 0.7%. 
- Trimethyl-(2-ethoxyethyl) ammonium bromide (7) 
To a stirred solution of trimethylamine (6.2 ml, 26 mmol; 4.2 M in ethanol), bromo-2-
ethoxy ethane (2.5 ml, 20 mmol) was added drop-wise with ice-cooling. The solution 
was allowed to stir for 3 days at room temperature and subsequently diluted with 
isopropanol (10 ml). The resulting solid reaction product was isolated by filtration and 
washed with isopropanol ( 2 x 15 ml) and dried under reduced pressure to yield 2.55 
g (72% yield) of a solid. 1H-NMR (CD3OD) δ 3.9 (m, 2H), 3.7 (m, 2H), 3.6 (q, 2H), 3.3 
(s, 9H), 1.3 (t, 3H). Content: 94.5% ± 4.3% 
-  Trimethyl-(pentyl) ammonium iodide (8) 
The synthesis was carried out according to the procedure of Menger & Venkataram 
(1986) with some modifications. Pentyl iodide (0.7 ml, 5.1 mmol) was treated with 
trimethylamine (2.4 ml, 10 mmol; 4.2 M in ethanol) at room temperature for 20 h in a 
sealed pressure tube. The reaction mixture was poured into 50 ml of ether, stirred, 
filtered and washed with ether to give 1.4 g (98% yield) of a solid.  1H-NMR δ 3.3 (m, 
2H), 3.1 (s, 9H), 1.8 (m, 2H), 1.4 (m, 4H), 0.9 (t, 3H). Content: 101.5% ± 2.0%. 
- Trimethyl-(4-oxopentyl) ammonium iodide (6) 
The Finkelstein reaction was carried out according to the procedure of Chiarello & 
Joullie (1988). 5-Chloro-2-pentanone (1.2 ml, 10 mmol) and sodium iodide (15 g, 100 
mmol) in 50 ml of acetone were allowed to reflux for 20 h. The reaction mixture was 
cooled under stirring to prevent clotting of precipitated salts, diluted with 100 ml of 
ether and filtered. The filtrate was washed with saturated NaCl solution and 20% 
Na2S2O3 solution, dried over MgSO4, filtered and evaporated to dryness under 
reduced pressure. The resulting 5-iodo-2-pentanone (2.1 g, 9.8 mmol) was used for 
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the subsequent reaction with trimethylamine (3.6 ml, 15 mmol; 4.2 M in ethanol) as 
described for product (8). Product obtained as solid: 1.1 g (42% yield). 1H-NMR δ 3.3 
(m, 2H), 3.1 (s, 9H), 2.7 (t, 2H), 2.2 (s, 3H), 2.0 (m, 2H). Content: 91.5% ± 0.8%. 
 
 
 
 
Results 
 
Identification of Lucilia cuprina genes encoding for nicotinic acetylcholine receptor 
subunits, cDNA isolation and bioinformatics analysis 
For the identification of nAChR α1 and α2 subunit genes of L. cuprina, 
degenerate primer pairs were deduced from conserved peptide sequences (Fig. 1). 
Degenerate primer reverse transcription (RT)-PCR was performed using total RNA 
isolated from L. cuprina heads. RT-PCR products of the expected size (~150 bp) 
were cloned and sequenced. Two different types of sequences were identified (seq1 
and seq 2, see Experimental procedures). The deduced protein sequences of the 
degenerate primer RT-PCR products showed extensive sequence identities to the 
corresponding regions of the Drosophila melanogaster α1 and α2 (Dmα1 and Dmα2, 
respectively) subunit genes (NM_79757/X53583). The peptide sequence from seq1 
was slightly closer to Dmα1 than to Dmα2, while the translated seq2 was slightly 
more homologous to Dmα2. The missing cDNA sequences of the corresponding L. 
cuprina nicotinic receptor α1 and α2 genes were obtained by 5’- and 3’-RACE using 
fly head total RNA as template. Based on the deduced start and stop codon positions 
in the 5’- and 3’-RACE product sequences of L. cuprina nicotinic receptor α1 
(accession numbers KC134196 and KC134197, respectively), and nicotinic receptor 
α2 (accession numbers KC134199 and KC134200, respectively), PCR primers were 
then designed for the RT-PCR amplification of the respective full length genes from 
total RNA. In the case of L. cuprina nicotinic receptor α1, an RT-PCR product with a 
1689 bp open reading frame [ORF (lca1)] was identified (accession number 
KC134198), while for L. cuprina nicotinic receptor α2, the amplicon comprised an 
ORF of 1692 bp (lcα2; accession number KC134201). Consensus sequences devoid 
of PCR errors were identified by the sequencing of four and five independent 
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plasmid-cloned PCR fragments in the case of lcα1 and lcα2, respectively, and by 
direct PCR product sequencing.  
The deduced polypeptide sequence of these new L. cuprina genes, lcα1 and 
lcα2, showed some sequence identity with each other (57.6%) and strong sequence 
identity with corresponding nicotinic receptor α1 and α2 subunits from other insect 
species, particularly D. melanogaster α1 (ALS, NM_079757) and α2 (SAD, X53583) 
with 92.9 and 90.6%, respectively, and Ctenocephalides felis (cat flea) α1 
(FR689743) and α2 (FR689746) subunits (Fig. 1) with 80.1 and 83.5%, respectively. 
To a lesser degree there was homology to α2 (X81888) and α1 (X81887) subunits of 
the hemimetabolous insect Myzus persicae, with peptide sequence identities of 71.3 
and 69.4%, respectively. Construction of a DNAStar/ClustalW-based molecular tree 
(Fig. 2) confirmed that the lcα1 and lcα2 genes belong to the insect nicotinic receptor 
subunit α1 and α2 families, respectively.  
 Inspection of the sequence of the Lcα1 and Lcα2 polypeptides with 
bioinformatics tools revealed within the predicted extracellular domains the presence 
of the cysteine loop and the loop A-C motifs typical for nicotinic receptor α subunit 
ligand-binding sites (Arias, 1997; Corringer et al., 2000; Albuquerque et al., 2009; 
Fig. 1). These loops contained a number of highly conserved amino acid residues: 
within the cysteine loop the two cysteines corresponding to C128 and C142 in the 
reference Torpedo α subunit; in loop A the amino acid residues corresponding to 
tryptophane W86 and tyrosine Y93; in loop B residues corresponding to W149 and Y151; 
and within loop C amino acids corresponding to C192 and C193 as well as Y190 and 
Y198 (all Torpedo α subunit numbering; Arias, 1997; Corringer et al., 2000; 
Albuquerque et al., 2009, Fig. 1). Kyte–Doolittle hydrophobicity plots of Lcα1 and 
Lcα2 suggested the presence of N-terminal endoplasmic reticulum (ER) import signal 
sequences and of several transmembrane regions in all three polypeptide sequences 
(not shown). Analysis of the two L. cuprina nicotinic receptor α subunit sequences 
with Signal P4.0 showed an ER import signal sequence probability of 0.848 for Lcα1, 
with a predicted cleavage site between A21 and N22, and for Lcα2 a probability of 
0.930 with a predicted cleavage site between A32 and N33 (Fig. 1). Further analysis 
with the transmembrane helix detection program TMHMM predicted in both gene 
products the four transmembrane helices typical for nAChR subunits and ligand-
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gated ion channels (LGIC) in general (Fig. 1 and data not shown; Arias, 1997; 
Corringer et al., 2000; Albuquerque et al., 2009). Within and neighbouring the second 
transmembrane helices TM2, the highly conserved amino acid residues of the 
nAChR ion channel ‘rings’ corresponding to D234, E237, S240, T244, L247, V251, L254 and 
E258 (chicken α7 subunit numbering, Corringer et al., 2000) are either also present in 
Lcα1 and Lcα2, or replaced by structurally and/or functionally similar amino acids 
(Fig. 1; S240 → A, Lcα2; V251 → M, Lcα2, T244 → S, Lcα1 and Lcα2; chicken α7 
numbering, Corringer et al., 2000). A search for potential N-glycosylation sites using 
NetNGlyc 1.0 revealed two fully conserved consensus sequences with high scores in 
the algorithm in Lcα1 and Lcα2 at the amino acid positions 45 and 233, and at the 
positions 56 and 245, respectively. As they are located in the putative extracellular 
domains of the receptor subunits, it appears likely that they are occupied by N-
glycans in the mature receptor protein. In Lcα2 three further potential N-glycosylation 
motifs were identified at positions 389, 407 and 557; however, the TMHMM algorithm 
predicted that the motifs at 389 and 407 are located within an intracellular loop and 
are therefore most likely not modified by the N-glycosylation machinery in the ER. 
The motif at 557 was predicted to be in the short extracellular C-terminal tail of the 
receptor. It is also present in Dmα2 and may carry an N-glycan in the mature protein. 
 
 
Functional characterization of Lcα1 and Lcα2. 
Co-expression of Lcα1 and Lcα2 as hybrid receptors with chicken β2 (Ggβ2, 
Bertrand et al., 1994) resulted in functional receptors that responded to acetylcholine 
by dose-dependent currents (Fig. 3A,B). Generally, expression of Lcα2/Ggβ2 
receptors led to stronger currents (range 5–20 µA) upon acetylcholine stimulation 
compared with Lcα1/Ggβ2 (range 1–2 µA). By contrast, with respect to the effective 
concentration 50% (EC50), Lcα1/Ggβ2 proved to be much more responsive to 
acetylcholine-mediated channel opening (EC50 = 80 nM, Table 1) than Lcα2/Ggβ2 
(EC50 = 5.37 µM, Table 1). Lcα1/Ggβ2 was sensitive to α-bungarotoxin block of 
acetylcholine agonist action, while Lcα2/Ggβ2 was unaffected by this snake toxin 
(Fig. 3C). Nicotine was a partial agonist of Lcα1/Ggβ2 [maximum response in the 
experiment (Imax) ~ 11.6%] with an EC50 of ~ 20 nM, while this tobacco alkaloid was a 
full agonist of Lcα2/Ggβ2 (Imax ~ 100%), but with much lower potency (EC50 ~ 940 
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nM, Table 1). Since repeated nicotine application resulted in pronounced receptor 
run-down of both Lcα1/Ggβ2 and Lcα2/Ggβ2 that could not be reversed by washing 
(data not shown, and Fig. 6C), the EC50 and Imax values have to remain tentative and 
Hill coefficients were not determined. The tree frog alkaloid epibatidine (Badio & 
Daly, 1994) led to irreversible channel opening in the case of Lcα1/Ggβ2 (Fig. 3D), 
while with Lcα2/Ggβ2 (Fig. 3E), it acted as an extremely potent full agonist whose 
repeated application led to receptor run-down (data not shown) (tentative EC50 = 7 
nM, tentative Imax = 100%; Table 1, Fig. 3E). The neonicotinoid imidacloprid was a 
highly potent partial agonist of Lcα1/Ggβ2, which gave rise however to only small 
currents (tentative EC50 = 20 nM, Imax = 5.1%). For Lcα2/Ggβ2, this insecticide was a 
full agonist (Imax = 104%) with some cooperativity (nH = 1.52) and an EC50 of 620 nM 
(Table 1, Fig. 5F).  
 
 
Chemical compounds for structure–activity relationships of acetylcholine backbone 
derivatives: purchase, synthesis and analytics 
To obtain a more detailed picture about the structural requirements for agonist 
action on Lcα1 and Lcα2-containing nAChRs, a collection of 13 close derivatives of 
the natural ligand acetylcholine was assembled (structures 1–14, Fig. 4B). 
Acetylcholine and five derivatives (1, 4, 9, 10, 12, 13) could be purchased, while eight 
further compounds (2, 3, 5, 6, 7, 8, 11, 14) were synthesized in the present study as 
their bromide or iodide salts. The compound identity was confirmed by 1H-NMR. 
Purity and content of the synthesis products were assessed by 1H-NMR 
quantification and were uniformly >90%.  
 Five centres for derivatization of acetylcholine were chosen (R1, R2, R3, X, R4; 
Fig. 4A): first, one methyl group (R1) of the quaternary ammonium group was 
replaced by ethyl (2) and n-propyl (3). The ethylene group was substituted by methyl 
either in the α- (R2) or in the β-position (R3) yielding rac-α-methylcholine (5) and rac-
β-methylcholine (4), respectively. The choline oxygen (X) experienced the most 
modifications: replacement of the oxygen by sulphur led to acetylthiocholine (9), 
while replacement by a methylene group yielded trimethyl-(4-oxopentyl)-ammonium 
(6). Homologation of the ethylene group by one carbon led to acetylhomocholine  
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Consensus  ............................................DAKRLYDDLLSNYNRLIRPV.NN.D...VK.GL.LSQ.I..NL..QI.TTNVW.E. 
           ---------+---------+---------+---------+---------+---------+-----NG -+---------+---------+---------+ 
                    10        20        30        40        50        60        70        80        90        100 
           ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
Mp-a1.pro  ----------------------LRAADVVPALLLLSAVGCLCNPDAKRLYDDLLSNYNRLIRPVSNNTDTVLVKLGLRLSQLIELNLKDQILTTNVWLEH         78 
Mp-a2.pro  ----------------MKIICAIFASVIVGQLAMPYAS-VYGSADAKRLYDDLLSNYNRLIRPVGNNSDRLTVKMGLKLSQIIEVNLRNQIMTTNVWVEQ         83 
Dm-ALS.pro ------------------MGSVLFAAVFI---ALHFATGGLANPDAKRLYDDLLSNYNRLIRPVGNNSDRLTVKMGLRLSQLIDVNLKNQIMTTNVWVEQ         79 
Dm-SAD.pro MAPGCCTTRPRPIALLAHIWRHCKPLCLLLVLLLLCET-VQANPDAKRLYDDLLSNYNRLIRPVSNNTDTVLVKLGLRLSQLIDLNLKDQILTTNVWLEH         99 
Lc-a1.pro  ------------------MGSVLFAAVFI---ALHFATGGLANPDAKRLYDDLLSNYNRLIRPVGNNSDRLTVKMGLRLSQLIDVNLKNQIMTTNVWVEQ         79 
Lc-a2.pro  MS---------ALHYKSTLWCHLKWLCLLVVFILLCES-VQANPDAKRLYDDLLSNYNRLIRPVSNNTDTVLVKLGLRLSQLIDLNLKDQILTTNVWLEH         90 
 
            
Consensus  EW.D.K..W.P..YGGV..L.VPSEHIWLPDIVLYNNADG.Y.VT.MTKA.LH..GKV.W.PPAI.KS.CEI.V.YFPFD.QTC.MKFGSW.YDG....L 
           ---------+---------+---------+Loop A---+---------+---------+---------+  Cys Loop +----Loop B-------+ 
                    110       120       130       140       150       160       170       180       190       200 
           ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
Mp-a1.pro  EWADHKFIWEPLEYGGVKELYVPSEHIWLPDIVLYNNADGEYVVTTMTKAVLHHSGKVMWTPPAIFKSSCEIDVRYFPFDQQTCFMKFGSWSYDGNQINL        178 
Mp-a2.pro  EWNDYKLKWNPEDYGGVDTLHVPSEHIWLPDIVLYNNADGNYEVTIMTKAILHYTGKVVWKPPAIYKSFCEINVEYFPFDEQTCSMKFGSWTYDGYMMDL        183 
Dm-ALS.pro EWNDYKLKWNPDDYGGVDTLHVPSEHIWLPDIVLYNNADGNYEVTIMTKAILHHTGKVVWKPPAIYKSFCEIDVEYFPFDEQTCFMKFGSWTYDGYMVDL        179 
Dm-SAD.pro EWQDHKFKWDPSEYGGVTELYVPSEHIWLPDIVLYNNADGEYVVTTMTKAILHYTGKVVWTPPAIFKSSCEIDVRYFPFDQQTCFMKFGSWTYDGDQIDL        199 
Lc-a1.pro  EWNDYKLKWNPDDYGGVDTLHVPSEHIWLPDIVLYNNADGNYEVTIMTKAILHHTGKVVWKPPAIYKSFCEIDVEYFPFDEQTCFMKFGSWTYDGYMVDL        179 
Lc-a2.pro  EWQDHKFKWDPSEYGGVTELYVPSEHIWLPDIVLYNNADGEYVVTTMTKAILHYTGKVVWTPPAIFKSSCEIDVRYFPFDQQTCFMKFGSWTYDGDQIDL        190 
 
            
Consensus  .H..Q..........GIDL..YY.SVEWDI..VPA.R.EK.Y.CC.EPY.DI.FN.TLRR.TLFYTVNLI.P.VGIS.LSVLVFYLP..S.EK..LCI.I 
           ---------+---------+---------+---------+-  Loop C-+---NG---+---------+----TM1--+---------+---------+ 
                    210       220       230       240       250       260       270       280       290       300 
           ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
Mp-a1.pro  KHIGQLVG-TNKVDVGIDLSAYYPSVEWDILGVPAERHEKYYSCCAEPYIDIFFNITLRRRTLFYTVNLIVPCVGISYLSVLVFYLPADSKEKISLCITI        277 
Mp-a2.pro  RHISQAPD-SDVIEVGIDLQDYYLSVEWDIMGVPAVRHEKFYVCCEEPYLDIFFNITLRRKTLFYTVNLIIPCVGISFLSVLVFYLPSESGEKVSLCISI        282 
Dm-ALS.pro RHLKQTAD-SDNIEVGIDLQDYYISVEWDIMRVPAVRNEKFYSCCEEPYLDIVFNLTLRRKTLFYTVNLIIPCVGISFLSVLVFYLPSDSGEKISLCISI        278 
Dm-SAD.pro KHISQKNDKDNKVEIGIDLREYYPSVEWDILGVPAERHEKYYPCCAEPYPDIFFNITLRRKTLFYTVNLIIPCVGISYLSVLVFYLPADSGEKIALCISI        299 
Lc-a1.pro  RHLKQTPD-SDNIEVGIDLQDYYISVEWDIMRVPAVRNEKFYSCCEEPYLDIVFNLTLRRKTLFYTVNLIIPCVGISFLSVLVFYLPSDSGEKISLCISI        278 
Lc-a2.pro  KHINQKNDKDNKVEIGIDLREYYPSVEWDILGVPAERHEKYYPCCAEPYPDIFFNITLRRKTLFYTVNLIIPTVGISYLSVLVFYLPADSGEKIALCISI        290 
 
            
Consensus  LLS.T.FFLL..EIIP.TSL..PLLGKYLLFTM.LV.L.V..T....N...R.P.TH....W....FI..LPK.L....P.................... 
           --TM2----+---------+---------+--------TM3--------+---------+---------+---------+---------+---------+ 
                    310       320       330       340       350       360       370       380       390       400 
           ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
Mp-a1.pro  LLSQTMFFLLISEIIPSTSLSLPLLGKYLLFTMLLVALCVVVTIIIINIHYRQPSTHKIPSWMRTVFIRALPKMLLMRVPEQ--------LLADSAMKQK        369 
Mp-a2.pro  LLSLTVFFLLLVEIIPPTSLTVPLLGKYLLFTMVLVTLSVFVTVAVLNVNFRSPVTHKMRPWVVKLFIQILPKVLFIERPKKGDSIDEDDDDDDEKHGEI        382 
Dm-ALS.pro LLSLTVFFLLLAEIIPPTSLTVPLLGKYLLFTMMLVTLSVVVTIAVLNVNFRSPVTHRMAPWVQRLFIQILPKLLCIERPKK----EEP---EEDQPPEV        371 
Dm-SAD.pro LLSQTMFFLLISEIIPSTSLALPLLGKYLLFTMLLVGLSVVITIIILNIHYRKPSTHKMRPWIRSFFIKRLPKLLLMRVPKD--------LLRDLAANKI        391 
Lc-a1.pro  LLSLTVFFLLLAEIIPPTSLTVPLLGKYLLFTMMLVTLSVVVTIAVLNVNFRSPVTHRMAPWVQKVFIDILPKLLCIERPKK----DESNDEEDDQPQEV        374 
Lc-a2.pro  LLSQTMFFLLISEIIPSTSLALPLLGKYLLFTMLLVGLSVVITIIILNIHYRKPSTHRMAPWVRSFFIKRLPKLLLMRVPND--------LLRDLAASKV        382 
 
            
Consensus  ............................P....................................................................... 
           ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
                    410       420       430       440       450       460       470       480       490       500 
           ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
Mp-a1.pro  QMKT-CKKLNLNLAR-LNAASVGATLNVPPAPVASP-P-------PG-----HRSPTD-------------SLRRFVAATGRTGCN---GTAAAAGAASR        438 
Mp-a2.pro  LSGVFDVPSEIDKYLGYN-RGYSFDYDVPPPLPSSRYCGARAVCAGGVNGGAGVSAGAGAVTGSNDTVVNMASDEDEDAIELDAEDEYDDMFSPTTTTDD        481 
Dm-ALS.pro LTDVYHLPPDVDKFVNYDSKRFSGDYGIP-ALPASHRF--------DLAAAGGISAHC------------FAEPPLPSSLPLPGAD--DDLFSPSGLNGD        448 
Dm-SAD.pro NYGLKFSKTKFGQAL-MDEMQMNSGGSSPDSLRRMQGR-------VGAGGCNGMHVTT-------------ATNRFSGLVGALGG----GLSTLSGYNG-        465 
Lc-a1.pro  LTDVFHLPPDVDKFVNYDTKRFSGDYGIP-ALPAQRFS--------EFAGTAGI-AQC------------FGDPPLPSALPLPGAD--DDLFSPTTVNGD        450 
Lc-a2.pro  NYGMNFNKTKFGKAL-MDEMNINSGNSSPDSIRRMQGR-------VG----NGLSSAS-------------ATNRFSGMMGVLGG----GLSTLSGYNG-        452 
 
            
Consensus  ..................................I....FI..H....D.......DW..VAMV.DR.FLW.F......GT..I...AP.LYD....ID. 
           ---------+---------+---------+---------+---------+---------+---------+------TM4+---------+---------+ 
                    510       520       530       540       550       560       570       580       590       600 
           ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
Mp-a1.pro  -LVNAAVSS--IDDTLNEVPAAIRKKYPFELEKAIHNVKFIQHHLQRQDEYNTEDQDWGFVAMVLDRLFLWIFTVASIMGTILILCEAPALYDDTKPIDR        535 
Mp-a2.pro  GLASPTFESHHHHHQHQHGCPVDQQPRHDPAMQTIQDAKFIAQHVKNQDKFDEIIEDWQYVAMVLDRLFLWIFTCACLIGTALIIFQAPALYDKTKPIDV        581 
Dm-ALS.pro --ISPGCCPAAAAAAAADLSPTFEKPYAREMEKTIEGSRFIAQHVKNKDKFESVEEDWKYVAMVLDRMFLWIFAIACVVGTALIILQAPSLYDQSQPIDI        546 
Dm-SAD.pro --LPSVLSG--LDDSLSDVAA--RKKYPFELEKAIHNVMFIQHHMQRQDEFNAEDQDWGFVAMVMDRLFLWLFMIASLVGTFVILGEAPSLYDDTKAIDV        559 
Lc-a1.pro  --LSPSCC-------QADLSPTFDKPYVGEMEKTIEGSRFIAQHMKNKDKFESVEEDWKYVAMVLDRLFLWIFTISCVVGTAWIILQAPSLYDQSQPIDI        541 
Lc-a2.pro  --LPSVLSG--LDDSLSDVAP--RKKYPFELEKAIHNVMFIQNHMQRQDEFNAEDQDWGFVAMVLDRLFLWIFAIASLVGTFMILGEAPSLYDDTKPIDV        546 
 
            
Consensus  ..S..A...............- 
           ---------+NG-------+-- 
                    610       620 
           ---------+---------+-- 
Mp-a1.pro  DLSFIARKQFSPTSDLE                                                                                           552 
Mp-a2.pro  VYSKIAKKKLQAIL                                                                                              595 
Dm-ALS.pro LYSKIAKKKFELLKMGSENTL.                                                                                      568 
Dm-SAD.pro QLSDVAKQIYNLTEKKN.                                                                                          577 
Lc-a1.pro  LYSKIAKKKFELLKMGSDTNL.                                                                                      563 
Lc-a2.pro  ELSVIAQQIYNLTEKKS.                                                                                          564 
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(11), while replacement of the acetyl group by -H or by –PO3
2- led to choline (12) and 
phosphocholine (13), respectively.Inversion of the ester moiety in acetylcholine led to 
its corresponding methyl ester (14). Removal of the carbonyl oxygen in acetylcholine 
(X = CO → X = CH2, Fig 4A) led to the choline ethyl ether (7), while simultaneous 
replacement of the ether oxygen by methylene resulted in trimethyl-pentyl ammonium 
(8). Replacing one methyl group in acetylcholine by amino (R4 = COCH3 → R
4 = 
CONH2, Fig 4A) led to carbamoylcholine (10). Taken together, these 13 compounds 
represent a comprehensive set of acetylcholine derivatives for structure-activity 
relationship studies of agonist potencies on nAChRs. 
 
Figure 1. CLUSTALW amino acid sequence alignment of Lucilia cuprina nicotinic acetylcholine (ACh) receptors (nAChR) α subunits. The 
predicted endoplasmic reticulum (ER) import signal sequences are highlighted by grey shading of black letters, and the predicted cleavage 
site is indicated by a grey triangle. The conserved tyrosine and tryptophane residues within the loop structures are marked with filled 
triangles, while the half-cystines of the Cys loops and the ligand binding sites are highlighted by connected open circles. The conserved 
amino acid residues forming the nAChR ion channel ‘ring’ in and near TM2 (Corringer et al., 2000) are highlighted by black circles (full 
conservation) or grey circles (partial conservation). The two conserved N-glycosylation sites in the extracellular domain (NG) are shown 
under the consensus sequence and are highlighted by light grey shading of white letters. The conserved extracellular loop structures (loop 
A, Cys loop, loop B, loop C) and the four predicted transmembrane helices (TM1–TM4) are highlighted by black bars under the consensus 
sequence. The black arrows indicate the conserved NicRα subunit peptide sequences used for the construction of degenerate PCR 
primers. 
 
 
Figure 2. Amino acid sequence identity relationships of Lcα1 and Lcα2 to other insect nicotinic acetylcholine receptor subunits: 
phylogenetic dendrograms. The dendrogram (DNAStar) was derived from CLUSTALW-aligned protein sequences of Lcα1 (KC134198) 
and Lcα2 (KC134201) identified in this study (highlighted by black arrows) together with the Drosophila melanogaster α subunits 1–3 
(Dmα1-α3, accession No: NM_079757, X53583, Y15593, respectively) as well as the α1–3 sequences of Anopheles gambiae (Agα1-α3; 
accession No: AY705394, AY705395, AY705396, respectively), of Apis mellifera (Amelα1-α3; accession No: DQ026031, NM_001011625, 
DQ026032, respectively), of Tribolium castaneum (Tcas-α1-α3; accession No: EF526080, EF526081, EF526082, respectively) and of 
Ctenocephalides felis (Cfα1-α3; accession No: FR689743, FR689746, FR689749, respectively) was constructed using DNAStar. In 
addition, the α1–2 sequences from Myzus persicae (Mperα1-α2, accession No: X81887 and X81888, respectively), and, for reference, 
Gallus gallus (chicken) α4 and β2 (Ggα4, Ggβ2; accession No: AJ250361 and AJ250362, respectively) were included. D. melanogaster 
GABA-gated chloride channel (Dm-GABA; accession No: M69057) served as an outgroup. 
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Structure–activity and structure–selectivity relationships of acetylcholine backbone 
analogues on Xenopus oocyte-expressed Lcα1/Ggβ2, Lcα2/Ggβ2 and Ggα4/Ggβ2 
nicotinic acetylcholine receptors 
Derivatives with modification of R1: investigation of the quarternary amine. 
Replacement of one N-methyl group by ethyl in acetylcholine (compound (2), Fig. 4B) 
led in Xenopus oocyte voltage clamp experiments to EC50 values equal to or even 
lower than those for acetylcholine in the case of Lcα1/Ggβ2 and Lcα2/Ggβ2 nAChR, 
respectively. By contrast, in the case of the chicken ganglionic nAChR Ggα4/Ggβ2, 
the EC50 rose by a remarkable three orders of magnitude (factor 964) for acetyl-N-
ethylcholine (2) relative to acetylcholine (Tables 1 and 2, Fig. 5A, B). Imax 
determinations showed that acetyl-N-ethylcholine (2) behaves as a non-cooperative 
partial agonist in the case of Lcα1/Ggβ2, as a full agonist with some cooperativity in 
the case of Lcα2/Ggβ2, and as a non-cooperative superagonist for Ggα4/Ggβ2 
(Tables 1 and 2). In the case of acetyl-N-propylcholine (3), the EC50 values rose 
moderately relative to the acetylcholine EC50 values for both Lcα1/Ggβ2 and 
Lcα2/Ggβ2, where this derivative behaved as a partial agonist with noncooperative 
and partially cooperative curve characteristics, respectively (Tables 1 and 2). In the 
case of chicken Ggα4/Ggβ2, the EC50 of this noncooperative partial agonist rose by 
two orders of magnitude (factor 101) relative to acetylcholine.  
Derivatives with modification of R2: investigation of backbone methyl substitutions. 
Substitution of the acetylcholine methylene group next to the choline oxygen by a 
methyl group [acetyl-β-methylcholine, (4)] led to strong increases in EC50 for both 
receptors Lcα1/Ggβ2 and Ggα4/Ggβ2, by factors of 287 and 830, respectively. In the 
case of Lcα1/Ggβ2, acetyl-β-methylcholine (4) acted as a weakly cooperative partial 
agonist, while for the chicken nAChR Ggα4/Ggβ2, this compound was a full agonist 
displaying some cooperativity (Tables 1 and 2). In the case of Lcα2/Ggβ2, a marked 
receptor run-down of the ion channel function was noticed (Fig. 6A) for the weak 
partial agonist (4) (Table 2). The densitization could not be reversed by prolonged 
washing (Fig. 6A); therefore, EC50 determinations could only be performed tentatively 
and yielded a value of ~ 455 µM, some 85-fold higher than for acetylcholine (Tables 1 
and 2).  For the isomeric acetyl-α-methylcholine (5), very different results were 
observed: for both insect α-subunit-containing nAChR (Lcα1/Ggβ2, Lcα2/Ggβ2), the 
EC50 values remained in the same range as for their natural ligand acetylcholine, 
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while in the case of the chicken nAChR Ggα4/Ggβ2, the EC50 rose by a factor of 427 
relative to acetylcholine (Tables 1 and 2, Fig. 5A and 5C). This compound acted as a 
noncooperative partial agonist, a partially cooperative full agonist and a negatively 
cooperative superagonist with Lcα1/Ggβ2, Lcα2/Ggβ2 and Ggα4/Ggβ2, respectively. 
 
 
 
Figure 3. Electrical current responses of heteromeric nicotinic acetylcholine (ACh) receptors (nAChRs) with Lcα1 or Lcα2 or 
Ggα4 and Ggβ2 subunits. (A) ACh dose response of Lcα1/Ggβ2; (B) ACh dose response of Lcα2/Ggβ2; (C) α-bungarotoxin 
sensitivity of the ACh responses of Lcα1/Ggβ2 and Lcα2/Ggβ2; (D) Epibatidine dose response of Lcα2/Ggβ2; (E) Current 
response of Lcα1/Ggβ2 to epibatidine (EPI) (16); (F) Current responses of Lcα1/ Ggβ2, Lcα2/Ggβ2 and Ggα4/Ggβ2 to 
phosphocholine (PhCh) (13). 
 
 Figure 4. Chemical structures of 
acetylcholine (ACh) backbone 
derivatives for nicotinic acetylcholine 
(ACh) receptor (nAChR) structure-
activity relationships and of nicotinoids 
and imidacloprid. (A) Overview of ACh 
modifications. (B) Chemical structures: 
(1) ACh; (2) acetyl-N-ethylcholine; (3) 
acetyl-N-propylcholine; (4) acetyl-β-
methylcholine; (5) acetyl-α-
methylcholine; (6) trimethyl-(4-
oxopentyl) ammonium; (7) trimethyl-
ethoxyethyl ammonium; (8) trimethyl-
pentyl ammonium; (9) acetyl-
thiocholine; (10) carbamoylcholine; 
(11) acetyl-homocholine; (12) choline; 
(13) phosphocholine; (14) trimethyl-(3-
methoxy-3-oxopropyl) ammonium, (15) 
(–)-nicotine; (16) (1R,2R,4S)-(+)-6-(6-
chloro-3-pyridyl)-7 azabicyclo[2.2.1] 
heptane, epibatidine; (17) imidacloprid. 
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Derivatives of R4 and X: modification of the acetylcholine carboxylic ester. 
Replacement of the choline oxygen in acetylcholine (R4) by a methylene group (6) led 
to a moderate increase in EC50 by a factor of 6 and 3 relative to acetylcholine for the 
L. cuprina α-subunit-containing Lcα1/Ggβ2 and Lcα2/Ggβ2, where this compound 
acted as a noncooperative partial and partially cooperative full agonist, respectively. 
In the case of Gga4/Ggb2, (6) behaved as a noncooperative full agonist, but the EC50 
increased by a factor of 89 (Tables 1 and 2, Fig. 5A, D). Reduction of the 
acetylcholine carbonyl to a methylene group (7) resulted in a ligand of uniformly 
lower activity, with an increase in EC50 by 83-fold and 533-fold relative to 
acetylcholine for Lcα1/Ggβ2 and Ggα4/Ggβ2, and noncooperative partial agonist and 
negatively cooperative superagonist properties, respectively. Repeated application of 
(7) to Lcα2/Ggβ2 led to a marked receptor run-down of the ion channel function (data 
not shown). Therefore, EC50 determinations had to remain tentative and yielded a 
value of    ~ 215 µM for this partial agonist, some 40-fold higher than for acetylcholine 
(Tables 1 and 2). A very similar picture was observed for the alkyl derivative (8), 
except that Lcα2/Ggβ2 experienced no receptor run-down and the EC50 values 
increased by factors of 25, 16 and 94 relative to acetylcholine, respectively. 
Furthermore, this derivative was a full agonist and not a superagonist for Ggα4/Ggβ2 
(Tables 1 and 2). Replacement of the choline oxygen X by a sulphur atom 
[acetylthiocholine, (9)] as well as replacement of the acetyl group by a carbamoyl 
group [carbamoylcholine, (10)] led to a moderate increase in the EC50 values for 
Lcα1/Ggβ2 (6 and 18), Lcα2/Ggβ2 (17 and 30) and Ggα4/Ggβ2 (23 and 24) 
compared with the respective values for acetylcholine. These ligands showed no or 
only weak cooperativity in nAChR agonist action and behaved as partial (Lcα1/Ggβ2) 
and full agonists (Lcα2/Ggβ2, Ggα4/Ggβ2). For Lcα2/Ggβ2, repeated applications of 
acetylthiocholine led to pronounced irreversible receptor run-down (Fig. 6D), and 
both EC50 and Imax determination had to remain tentative, while Hill coefficients were 
not calculated (Tables 1 and 2). 
Derivatives with modification of R4 and X: mixed structural changes. Homologation of 
the ACh backbone from ethyl to n-propyl [acetylhomocholine, (11)] resulted in an 
agonist that showed a moderate loss in EC50 potency for Lcα1/Ggβ2 and Lcα2/Ggβ2 
by a factor of 24 and 31 compared with ACh and acted as noncooperative and 
weakly cooperative partial agonist, respectively. For chicken Ggα4/Ggβ2, (11) was a 
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full agonist with negative cooperativity, but the rise in EC50 (factor 549) was much 
stronger than for the insect α-subunit-containing nAChRs. Removal of the ACh acetyl 
group yielding choline (12) led to a dramatic increase of EC50 compared with ACh for 
all three nAChRs of this study (Lcα1/Ggβ2, Lcα2/Ggβ2, Ggα4/Ggβ2), by factors of 
506, 93 and 1296, respectively, and noncooperative partial agonist behaviour in the 
case of Lcα1/Ggβ2 and Ggα4/Ggβ2. For Lcα2/Ggβ2, receptor run-down was 
observed upon repeated application of choline (12) (Fig. 6B). Replacement of the 
acetyl group by a phosphate group led to a compound [phosphocholine, (13)] with 
agonist properties on all three receptors, albeit very weak on Lcα2/Ggβ2 (Fig. 3F). In 
the case of Lcα1/Ggβ2, phosphocholine (13) was a full agonist at very high 
concentrations (Fig. 3F). The detailed agonist properties of phosphocholine could not 
be assessed owing to low compound availability. The inversion of the ACh carboxylic 
group resulted in an agonist (14) that, remarkably, retained its potency and showed 
only low or moderate increases in EC50 relative to ACh for Lcα1/Ggβ2 and 
Lcα2/Ggβ2 (factors of 4 and 7, respectively), and which acted as a noncooperative 
partial agonist for Lcα1/Ggβ2 and a partially cooperative full agonist for Lcα2/Ggβ2. 
By contrast, the EC50 of (14) rose 405-fold compared with ACh for the chicken 
ganglionic nAChR Ggα4/Ggβ2, and acted as a negatively cooperative superagonist 
(Tables 1 and 2, Fig. 5A, F). 
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Figure 5: Hill curves of relative current responses of heteromeric nicotinic acetylcholine (ACh) receptors (nAChRs) with Lcα1 
or Lcα2 or Ggα4 and Ggβ2 subunits: Lcα1/Ggβ2 (●), Lcα2/Ggβ2 (▲) and Ggα4/Ggβ2 (■). (A) Dose responses with ACh (1); (B) 
dose responses with acetyl-N-ethylcholine (2); (C) dose responses with acetyl-α-methylcholine (5); (D) dose responses with 
trimethyl-(4-oxopentyl) ammonium (6); (E) dose responses with trimethyl-(3-methoxy-3-oxypropyl)ammonium (14); (F) dose 
responses with imidacloprid (17). Error bars indicate the SD from 2-11 data points. 
 
 
 
 
Figure 6: Repeated agonist application leading to receptor run-down of Lcα2/Ggβ2 expressed in Xenopus oocytes: (A) acetyl-
β-methylcholine (4); (B) choline (12); (C) (-)-nicotine (15); (D) acetylthiocholine (9). 
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Table 1: Xenopus oocyte-expressed nicotinic acetylcholine receptors: EC50 values and Hill coefficients 
nH of various agonists. 
 
compound 
EC50 
Lcα1/Ggβ2 
[µM] 
nH 
Lcα1/Ggβ2 
 
EC50 
Lcα2/Ggβ2 
[µM] 
nH 
Lcα2/Ggβ2 
EC50 
Ggα4/Ggβ2 
[µM] 
nH 
Ggα4/Ggβ2 
Acetylcholine iodide (1) 0.08 +/- 0.03 
(n=11) 
1.05 +/- 0.18 
(n=15) 
5.37 +/- 1.15 
(n=4) 
1.46 +/- 0.19 
(n=6) 
0.29 +/- 0.08 
(n=4) 
0.69 +/- 0.06 
(n=4) 
Acetyl- N-ethylcholine iodide 
(2) 
0.08 +/- 0.01 
(n=4) 
0.93 +/- 0.09  
(n=4) 
3.39 +/- 1.0 
(n=4) 
1.46 +/- 0.15 
(n=4) 
279.5 +/- 86 
(n=3) 
0.61 +/- 0.1 
(n=4) 
Acetyl-N-propylcholine iodide 
(3) 
1.27+/- 0.23 
(n=4) 
0.80 +/- 0.07  
(n=4) 
54.1 +/- 5.1 
(n=4) 
1.41 +/- 0.1 
(n=4) 
29.2 +/- 5.5 
(n=3) 
0.46 +/- 0.03 
(n=4) 
Acetyl-β-methylcholine 
chloride (4) 
22.9 +/- 6.0 
(n=4) 
1.24 +/- 0.18  
(n=4) 
approx♯. 
455.0 
n. g. 240.6 +/- 19.5 
(n=4) 
1.45 +/- 0.14 
(n=4) 
Acetyl-α-methylcholine iodide 
(5) 
0.19 +/- 0.02 
(n=5) 
0.93 +/- 0.15  
(n=5) 
12.8 +/- 2.5 
(n=3) 
1.37 +/- 0.08 
(n=4) 
123.7 +/- 38.5 
(n=4) 
0.59 +/- 0.08 
(n=7) 
Trimethyl-(4-oxopentyl) 
ammonium iodide (6) 
0.5 +/- 0.15 
(n=4) 
0.95 +/- 0.23  
(n=4) 
13.4 +/- 2.8 
(n=4) 
1.54 +/- 0.14 
(n=4) 
25.8 +/- 7.1 
(n=3) 
1.02 +/- 0.13 
(n=4) 
Trimethyl-ethoxyethyl 
ammonium bromide (7) 
6.6 +/- 1.2 
(n=4) 
1.24 +/- 0.11  
(n=4) 
approx♯. 
214.5 
n. g. 154.7 +/- 20.6 
(n=4) 
0.67 +/- 0.08 
(n=4) 
Trimethyl-pentyl ammonium 
iodide (8) 
2.0 +/- 0.84 
(n=3) 
0.88 +/- 0.07  
(n=4) 
86.1 +/- 4.4 
(n=4) 
1.57 +/- 0.14 
(n=4) 
27.3 +/- 0.1 
(n=3) 
0.79 +/- 0.06 
(n=4) 
Acetyl-thiocholine iodide (9) 0.44 +/- 0.1 
(n=3) 
0.96 +/- 0.05  
(n=3) 
approx♯. 89.7 n. g. 6.64 +/- 0.3 
(n=3) 
1.03 +/- 0.18 
(n=3) 
Carbamoylcholine chloride 
(10) 
1.46 +/- 0.42 
(n=4) 
0.95 +/- 0.13  
(n=4) 
161.8 +/- 
32.9 (n=3) 
1.15 +/- 0.29 
(n=5) 
7.0 +/- 2.2 
(n=4) 
0.72 +/- 0.07 
(n=5) 
Acetyl-homocholine iodide(11) 1.88 +/- 0.61 
(n=4) 
0.92 +/- 0.15  
(n=4) 
165.2 +/- 
38.7 (n=4) 
1.35 +/- 0.1 
(n=4) 
159.3 +/- 44.1 
(n=4) 
0.70 +/- 0.03 
(n=4) 
Choline bromide (12) 40.5 +/- 6.5 
(n=4) 
1.12 +/- 0.18 
(n=4) 
approx♯. 502 n. g. 375.7 +/- 50.3 
(n=5) 
1.19 +/- 0.11 
(n=5) 
Trimethyl-(3-methoxy-3-
oxopropyl) ammonium iodide 
(14) 
0.34 +/- 0.04 
(n=4) 
0.98 +/- 0.02  
(n=4) 
36.0 +/- 12.0 
(n=5) 
1.32 +/- 0.17 
(n=5) 
117.6 +/- 23.1 
(n=4) 
0.44 +/- 0.02 
(n=6) 
Nicotine (15) approx♯. 0.02 n. g. approx♯. 0.94 n. g. 0.76§ 1.1§ 
Epibatidine (16) n. d.* n. d.* 
approx♯. 
0.007 
n. g. n. d.* § n. d.* § 
Imidacloprid (17) approx♯. 0.02 n. g. 0.62 +/- 0.12 
(n=4) 
1.52 +/- 0.1 
(n=4) 
13.8§ 1.13§ 
 
The standard deviations and the number of repeats are indicated. ♯: only approximate values, because of loss of signal 
(‘receptor desensitization’) upon repeated ligand application (see examples in Fig. 6); therefore, the corresponding Hill 
coefficients are also not given (n.g.). *: not determined (n. d.) due to irreversible agonist action.  
§
: data taken from Dederer et al 
2011. The compound numbers in parentheses refer to the structures in Fig. 4B. 
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Table 2: Ratio of compound EC50 values to EC50 of the natural ligand acetylcholine, and compound 
Imax values relative to Imax acetylcholine. 
 
compound 
EC50/EC50 ACh 
Lcα1/Ggβ2 
Imax (%)
*
 
Lcα1/Ggβ2 
EC50/EC50 ACh 
Lcα2/Ggβ2 
Imax (%)
*
 
Lcα2/Ggβ2 
EC50/EC50 ACh 
Ggα4/Ggβ2 
Imax (%)
*
 
Ggα4/Ggβ2 
Acetylcholine iodide (1) 1 100 1 100 1 100 
Acetyl- N-ethylcholine 
iodide (2) 
1 
21.4# +/- 
2.1 (n=4) 
0.6 84.0$ +/- 0.6 (n=4) 964 
158.8‡ +/- 
26.0 (n=4) 
Acetyl-N-propylcholine 
iodide (3) 
15.9 
35.0# +/- 
7.0 (n=4) 
10.1 63.0$ +/- 8.4 (n=3) 100.7 56.4
‡ +/- 4.9 
(n=4) 
Acetyl-β-methylcholine 
chloride (4) 
286.6 
14.9# +/- 
3.3 (n=4) 
84.7§ approx. 1.7
$ +/- 0.5 
(n=4) 829.6 
87.9‡ +/- 
12.6 (n=4) 
Acetyl-α-methylcholine 
iodide (5) 
2.4 
19.9# +/- 
3.4 (n=5) 
2.4 81.5$ +/- 10.0 (n=4) 426.6 
141.4‡ +/- 
12.0 (n=4) 
Trimethyl-(4-oxopentyl) 
ammonium iodide (6) 
6.25 
48.5# +/- 
2.5 (n=4) 
2.5 103.0$ +/- 1.6 (n=4) 89 
113.9‡ +/- 
13.5 (n=4) 
Trimethyl-ethoxyethyl 
ammonium bromide (7) 
82.6 
38.6# +/- 
5.6 (n=4) 
39.9§ approx. 40.5
$ +/- 6.9 
(n=3) 
533.4 
120.4‡ +/- 
13.5 (n=4) 
Trimethyl-pentyl 
ammonium iodide (8) 
25.3 
28.1# +/- 
5.8 (n=4) 
16 81.2$ +/- 4.7 (n=3) 94.1 
106.3‡ +/- 
7.1 (n=4) 
Acetyl-thiocholine iodide 
(9) 
5.5 
57.6# +/- 
4.3 (n=3) 
16.7§ approx. 94.8
$ +/- 5.4 
(n=4) 22.9 
100.7‡ +/- 
3.9 (n=4) 
Carbamoylcholine 
chloride (10) 
18.3 
78.9# +/- 
16.3 (n=4) 
30.1 97.3$ +/- 12.7 (n=6) 24 
112.6‡ +/- 
4.6 (n=4) 
Acetyl-homocholine 
iodide(11) 
23.5 
17.9# +/- 
4.0 (n=3) 
30.8 51.0$ +/- 6.9 (n=4) 549.4 
107.4‡ +/- 
13.9 (n=4) 
Choline bromide (12) 505.6 
28.5# +/- 
3.8 (n=4) 
93.4§ approx. 9.9
$ +/- 1.7 
(n=6) 
1295.5 81.7
‡ +/- 3.3 
(n=4) 
Phosphocholine (13) n. d. > 90# n. d. < 5$ n. d. > 40‡ 
Trimethyl-(3-methoxy-3-
oxopropyl) ammonium 
iodide (14) 
4.25 
60.4# +/- 
2.0 (n=4) 
6.7 126.4$ +/- 6.6 (n=4) 405.4 
222.6‡ +/- 
18.4 (n=4) 
Nicotine (15) 0.25§ 
approx. 
11.6# +/- 
2.8 (n=4) 
0.18§ 
approx. 100.1$ +/- 
5.6 (n=4) 
2.7 84.2‡& 
Epibatidine (16) n. d. n.d. 0.001§ 
approx. 100.1$ +/- 
4.2 (n=4) 
n. d. n.d. 
Imidacloprid (17) 0.25§ 5.1
# +/- 0.9 
(n=4) 
0.12 104.0$ +/- 10.2 (n=4) 47.6 24.8‡& 
 
*: relative to Imax acetylcholine set at 100%; Imax (%) was determined at the following saturating agonist concentrations: 
# (2) 5 
µM, (3) 100 µM, (4) 250 µM, (5) 10 µM, (6) 20 µM, (7) 50 µM, (8) 100 µM, (9) 20 µM, (10) 50 µM, (11) 100 µM, (12) 500 µM, 
(13) 20 mM, (14) 20 µM, (15) 0.5 µM, (17) 3 µM. $ (2) 100 µM, (3) 1 mM, (4) 1 mM, (5) 500 µM, (6) 200 µM, (7) 1 mM, (8) 1 mM, 
(9) 1 mM, (10) 10 mM, (11) 5 mM, (12) 5 mM, (13) 20 mM, (14) 5 mM, (15) 10 µM, (16) 0.5 µM, (17) 10 µM. ‡ (2) 20 mM, (3) 5 
mM, (4) 5 mM, (5) 5 mM, (6) 1 mM, (7) 10 mM, (8) 2 mM, (9) 200 µM, (10) 5 mM, (11) 5 mM, (12) 10 mM, (13) 20 mM, (14) 20 
mM, (15) 10 µM,  (17) 200 µM. §: values based on the approximate EC50s of table 1. n.d.: not determined. 
&: data taken from 
Dederer et al 2011. The standard deviations and the number of repeats are indicated. Imax up to 79.9%: partial agonist; 80%-
119.9%: full agonist; ≥ 120%: superagonist. The compound numbers in parentheses refer to the structures in Fig. 4B. 
 
 
 
 
 
 
 
 
 
Paper II 
 
100 
Discussion 
 
In the present report we describe the identification and full-length cloning of 
two nAChR subunits from the sheep blowfly L. cuprina. Protein sequence homology 
analyses suggest that they belong to the insect nAChR α1 and α2 subunit families, 
respectively. Trans-species hybrid receptors with chicken nAChR β2 subunits 
expressed in Xenopus oocytes resulted in ACh-induced currents up to the low and 
high µA range for Lcα1/Ggβ2 and Lcα2/Ggβ2 receptors, respectively. The EC50 
values of 80 nM and 5.37 µM compared well with those determined for the cat flea 
and fruit fly nAChR α1 and α2 subunits in earlier studies (Bertrand et al., 1994; 
Dederer et al., 2011). The ACh sensitivity of Ggα4/Ggβ2 (Ballivet et al., 1988) 
determined in the present study was consistently in the nM range between the values 
for the L. cuprina α1 and α2 subunits (EC50 = 290 nM), and is in good agreement 
with earlier studies (Valera et al., 1992; Hussy et al., 1994), although somewhat 
higher values have also been reported (Shimomura et al., 2004; Dederer et al., 
2011). 
Further support for the notion of assigning these newly identified nAChR 
genes to the insect α1 and α2 groups comes from the α-bungarotoxin sensitivity of 
Lcα1 and the resistance of Lcα2, which are hallmarks of the respective gene families 
(Bertrand et al., 1994; Lansdell & Millar, 2000; Dederer et al., 2011). Epibatidine (16) 
irreversibly opens Lcα1/Ggβ2 ion channels at nM concentrations, while for 
Lcα2/Ggβ2 this alkaloid acts as an extremely potent (EC50 ~ 7 nM) desensitizing 
agonist. With respect to the responsiveness to the insecticidal market product 
imidacloprid (17), Lcα1/Ggβ2 possesses an EC50 in the nanomolar range, some 31-
fold lower than that of Lcα2/Ggβ2, and some 690-fold lower than that of the chicken 
nAChR Ggα4/Ggβ2, which may be indicative for its role as neonicotinoid in vivo 
target (Dederer et al.,  2011); however, while imidacloprid is a full agonist for 
Lcα2/Ggβ2, it is only a weak partial agonist for Lcα1/Ggβ2. The relationships of these 
findings for imidacloprid action in vivo remain to be determined.  
In the past, structure-activity and structure–selectivity studies for agonist 
action on native and recombinant insect nAChRs have focused on neonicotinoid 
derivatives (Ihara et al., 2003; Tomizawa & Casida, 2003, 2005, 2009; Shimomura et 
al., 2004; Millar & Denholm, 2007; Thany et al., 2007, and references therein) and on 
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spinosyns (Sparks et al., 2001; Perry et al., 2007; Baxter et al., 2010; Kirst, 2010, 
and references therein). By contrast, systematic structure-activity relationships for the 
natural ligand ACh as a lead structure have not been reported for insect nAChRs. 
Surprisingly, in vertebrate nAChR research, studies on close ACh derivatives appear 
to be fragmentary (Dale,  1914; Ing et al., 1952; Clark et al., 1968; Shefter & 
Mautner, 1969; Aronstam & Buccafusco, 1982; Auerbach et al., 1983; Aronstam et 
al., 1988), particularly on defined recombinant receptors (Zhang et al., 1995; Jensen 
et al., 2003; Jonnala et al., 2003), while most of current nicotinic agonist research is 
focused on aromatic and/or alkaloid ligands derived from epibatidine, nicotine or 
cytosine and others (Breining, 2004; Bunnelle et al., 2004; Cassels et al., 2005; 
Gündisch & Eibl, 2011). 
In the present study we have assembled a collection of 13 close ACh 
derivatives by chemical synthesis and compound purchase. The nAChR agonistic 
potential of this collection was analysed on the insect α subunit-containing 
Lcα1/Ggβ2 and Lcα2/Ggβ2, and in comparison, on the chicken neuronal receptor 
Ggα4/Ggβ2. The most remarkable differences with respect to the EC50 values were 
seen for acetyl-N-ethylcholine (2), which was as potent as or more potent on 
Lcα1/Ggβ2 and Lcα2/Ggβ2 than ACh, while the EC50 value of (2) on Ggα4/Ggβ2 
rose by a factor of almost 1000 as compared to ACh. Similarly, the EC50s of acetyl-α-
methylcholine (5) for Lcα1/Ggβ2 and Lcα2/Ggβ2 rose only moderately (factor 2.4) 
relative to ACh, while in the case of Ggα4/Ggβ2 the increase in EC50 for (5) was 
about 427-fold as compared to ACh. A third derivative, where the difference in EC50 
increases between insect and chicken receptors reached or exceeded the factor 100, 
was trimethyl-(3-methoxy-3-oxopropyl) ammonium (14), which basically corresponds 
to ACh with inverted ester function. Here, the EC50s relative to ACh for Lcα1/Ggβ2 
and Lcα2/Ggβ2 increased by modest 4.3 and 6.7-fold, while in the case of 
Ggα4/Ggβ2, this factor was 405. 
Amongst the derivatives with less dramatic receptor potency differences, for 
acetylhomocholine (11) a dramatic increase of EC50 was noted for Ggα4/Ggβ2 
(~550-fold) relative to ACh, while for the insect receptors Lcα1/Ggβ2 and Lcα2/Ggβ2, 
this was a more moderate 24-fold and 31-fold, respectively. Also trimethyl-(4-
oxopentyl) ammonium (6) retained much of the ACh potency in Lcα1/Ggβ2 and 
Lcα2/Ggβ2 with EC50 increases of 6.3 and 2.4, respectively, relative to ACh, while 
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the chicken receptor potency dropped by a factor of 89. For all other derivatives 
differences of EC50 losses between the three receptor forms relative to ACh were 
generally near or below a factor of 10, which made these derivatives less instructive. 
In general, it appears that Ggα4/Ggβ2 is much less forgiving to the moderate 
structural changes on ACh that are displayed by the derivatives investigated in the 
present study. EC50 increases were generally 2–3 orders of magnitude, except for the 
very close derivatives acetylthiocholine (9) and carbamoylcholine (10) (Tables 1 and 
2). By contrast, the less dramatic or non-existent EC50 rises for the insect receptors 
Lcα1/Ggβ2 and Lcα2/Ggβ2 suggest that particularly substitution at the ACh 
quarternary ammonium, branching and the length of the ACh alkyl chain between 
ammonium and ester function, ketone analogues of ACh as well as the inverted ACh 
ester structure could be sources for selectivity between insect and chicken nAChRs 
investigated in the present study and therefore logical entry points for derivatization 
programmes. As fruit fly and cat flea nicotinic receptor hybrid receptor data for the 
insect α1 subunit and neonicotinoids are in better accord with the insect in vivo 
toxicity of these compounds than for the insect α2 subunit (Dederer et al., 2011), and 
as neonicotinoid target site resistance has been shown to be associated with α1 
subunit mutations in Drosophila (Perry et al., 2008) and in Nilaparvata (Liu et al., 
2005, 2006, 2009), such derivatization programmes should initially focus on the 
insectα1/chickenβ2 nicotinic receptor combinations.  
The last decade has seen considerable progress in the structural biology of 
nAChR ligand-binding domains, in part with co-crystallized natural and drug ligands 
(Brejc et al., 2001; Celie et al., 2004; Rucktooa et al., 2009; Li et al., 2011). These 
developments also paved the way for molecular modelling of receptors without 
structural information as well as in silico pharmacophor and docking studies, with the 
aim of achieving structure-guided design of nAChR-addressing drugs (Taylor et al., 
2007; Ulens et al., 2009; Abin-Carriquiry et al., 2010; Akdemir et al., 2011; Kombo et 
al., 2012). The structure-activity and structure-selectivity relationships of ACh 
derivatives uncovered in the present study are ideal entry points for corresponding in 
silico studies on insect nAChR subunit-containing structural models (Tomizawa et al., 
2011).  
In summary, in addition to the identification and characterization of the 
previously unknown blowfly nAChR α subunits, our study has revealed hitherto 
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unknown structure-activity and structure-selectivity relationships of a comprehensive 
set of ACh derivatives on L. cuprina α1, L. cuprina α2 and chicken α4-containing 
nAChR hybrid receptors with chicken β2. Future studies will address other vertebrate 
nAChRs and the more extended structural space of ACh to probe in depth for insect 
nAChR selectivity potential. Both the most selective derivatives and the non-selective 
compounds arising of such an approach may serve for guidance in the quest for 
selective insecticides, either by wet bench or in silico methods.   
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